POPULARITY
Categories
151 episodes with collectively
46 episodes with collectively
128 episodes with collectively
53 episodes with collectively
64 episodes with collectively
38 episodes with collectively
25 episodes with collectively
22 episodes with collectively
22 episodes with collectively
11 episodes with collectively
16 episodes with collectively
11 episodes with collectively
12 episodes with collectively
66 episodes with collectively
22 episodes with collectively
7 episodes with collectively
16 episodes with collectively
10 episodes with collectively
6 episodes with collectively
17 episodes with collectively
5 episodes with collectively
9 episodes with collectively
10 episodes with collectively
12 episodes with collectively
9 episodes with collectively
14 episodes with collectively
6 episodes with collectively
6 episodes with collectively
7 episodes with collectively
7 episodes with collectively
7 episodes with collectively
4 episodes with collectively
4 episodes with collectively
4 episodes with collectively
13 episodes with collectively
4 episodes with collectively
2 episodes with collectively
4 episodes with collectively
5 episodes with collectively
4 episodes with collectively
5 episodes with collectively
6 episodes with collectively
3 episodes with collectively
3 episodes with collectively
4 episodes with collectively
4 episodes with collectively
8 episodes with collectively
13 episodes with collectively
6 episodes with collectively
11 episodes with collectively
3 episodes with collectively
3 episodes with collectively
4 episodes with collectively
3 episodes with collectively
5 episodes with collectively
2 episodes with collectively
2 episodes with collectively
3 episodes with collectively
2 episodes with collectively
5 episodes with collectively
10 episodes with collectively
2 episodes with collectively
2 episodes with collectively
Most organizations do not fail at strategy because the strategy is wrong. They fail because the organization never learns to behave as if the strategy is real. That is the central argument Dr. Kyle Harkema makes in his book Strategic Clarity. He is the creator of the Strategic Orientation Index (SOI™), a diagnostic tool that functions like an organizational MRI, revealing the hidden misalignment between what an organization says it will do and how it actually behaves day to day. In this conversation with Michael D. Levitt of Breakfast Leadership Network, Dr. Harkema explains why strategic drift is rarely dramatic, what the SOI™ measures, and how the three-part framework of think, listen, and act exposes exactly where execution breaks down inside even well-run organizations. Key Topics Covered Why strategy fails quietly. Strategic failure begins with small, easy-to-dismiss signals: the same decision recycled through multiple meetings, departments generating friction, customers noting a decline in responsiveness, or competitors gaining ground one step at a time. Individually, none of those signals is a crisis. Collectively, they signal drift, and organizations that catch the pattern early are the ones that survive disruption. The Monday Morning Test. If employee behaviors have not changed by Monday morning following a Friday strategy rollout, you have produced a plan, not an executable strategy. Strategy must live in decisions and priorities, not slide decks and town hall speeches. The Strategic Orientation Index (SOI™). The SOI™ evaluates three dimensions: how an organization thinks, listens, and acts. Most organizations are strong in one or two areas and significantly weaker in the third. Dr. Harkema shares a case study of an innovation-focused company with excellent thinking and acting but almost no process for collecting customer insight before making product decisions. The diagnosis was not an innovation problem. It was a listening problem. The Ford Taurus lesson. When Ford abandoned the Taurus, then the number one selling car in the world, for the retro Ford 500 name, the sales collapse was predictable and preventable. The organization thought carefully and acted decisively. It did not listen. The Taurus name was eventually restored, but the market position never recovered. Listening is not a soft skill. It is a strategic competency. Notable Quotes: "If your employees' behaviors don't change on Monday morning for a strategy that you rolled out on Friday, you have a plan, not an executable strategy." - Dr. Kyle Harkema "Strategy lives in behavior. It has to." - Dr. Kyle Harkema "When organizations aren't living and breathing the strategic plan, it limits the impact they cause." - Michael D. Levitt, Breakfast Leadership Network https://kylejharkema.com https://kmccontrols.com
After the biodiversity panel from the last episode, I got to thinking about how protecting biodiversity is so often reduced to the life forms that humans value. The ones we find beautiful, friendly, or otherwise useful to us directly. Cuddly mammals, majestic birds, colorful butterflies and flowers, etc. In many ways though, these living beings are only able to survive and thrive if the critters that we dislike are abundant in the same spaces. Many flowers are pollinated by bugs most would find annoying. A lot of cuddly mammals feed on weed species or our own crops. Eagles and owls need an abundance of rodents and reptiles if their populations are to grow. Many invasive exotic species are working tirelessly to restore damaged and imbalanced ecosystems. It's kinda like trying to lose body fat in just one area of your body. You can't just pick the parts that are desirable to you and expect the whole interconnected system to accept that. Collectively we need to embrace the restoration and stewardship, especially of the lower trophic levels of the food web that support all the higher levels above. In the last panel we touched a little on the tolerance and adaptation required to share space with predators and birds that threaten livestock and crops, recognizing their role despite the challenges that come from having them around. Today I'll be revisiting some of my favorite interviews from previous seasons in which we talked about three specific categories of overlooked and undervalued wildlife. My hope is that we can welcome these into a broader conversation about biodiversity, and maybe even convince you to work to promote greater diversity and open pollination of your crops and livestock, the full range of insects, and even rethink your management of invasive species in your land or on your farm.
A brief note. These episodes are prerecorded during a five-week period away. I am not tracking current events in real time. Hold what I offer here alongside what you are actually living.--The Wound Beneath Many WoundsThis is a week of significant arrivals. Venus in Leo moves through a rapid sequence of major contacts. Chiron crosses into Taurus, beginning nearly eight years of healing work in the realm of body, earth, and resource. And the week closes with the Sun entering Cancer at the Summer Solstice.Key Cycles This Week:Monday. June 15: Venus in Leo sextiles Uranus in Gemini. A liberating opening. Venus in Leo leans toward authentic self-expression. Uranus electrifies that impulse, breaking open stale patterns and quickening the creative field. Notice the difference between radiance that comes from genuine self-expression and the performance of radiance designed to manage how others see you. Uranus helps clarify which is which.Tuesday, June 16: Venus in Leo trines Neptune in Aries. Vision follows liberation. The heart and the imaginal field move in alignment. Creativity, inspiration, the sense that something more luminous is possible. In a collective field saturated with ugliness and cruelty, the capacity to remain open to beauty is not escapism. It is resistance. Let the imagination open today while holding what arises with gentle discernment.Wednesday, June 17: Venus in Leo opposes Pluto in Aquarius. The week deepens. Venus opposite Pluto surfaces power dynamics in relationship, places where love has become entangled with control or desire shadowed by fear of loss. Collectively this opposition names what has long been visible: the way systems of power have sought to control the feminine, the relational, the creative. Where in your own life has love or creative expression become entangled with power in ways worth examining? What is being asked to transform?Friday, June 19: Chiron enters Taurus, remaining until September 13 before briefly retrograding back into Aries, then returning to Taurus until May 2034. This is the threshold of the week. Perhaps of the year.Chiron in Aries since 2018 has been working the wounds of identity, the right to exist and assert a self in the face of systems that deny that right to so many. It has also been working the wound of radical disconnection from the web of life. The mythology of the rugged individual who needs no one and owes nothing. The belief that life is fundamentally competitive rather than reciprocal. The armoring against interdependence that produces its own profound poverty and loneliness.That wound does not end as Chiron moves into Taurus. It deepens into new territory.Chiron in Taurus turns the healing work toward the body, the earth, and the deep unmetabolized wounds in our relationship to the living world. The wound of an economy built on extraction, of profound inequality where abundance exists alongside deprivation by design, of a civilization that severed its understanding that the earth is not a resource to be used but a living web of which we are part.Nearly eight years. A generational healing arc is beginning. Honor the threshold.Sunday, June 21: Sun enters Cancer. Summer Solstice and Sun sextiles Chiron in early Taurus. The longest day in the northern hemisphere. A sacred pause in earth-based traditions, a moment to feel the fullness of what has been growing and to honor the turn. The Sun sextiling Chiron freshly arrived in Taurus is a gentle blessing on this new healing arc, the light of the Solstice illuminating what Chiron has come to work with. Spend time in the natural world if you can. Let the body be held by something older and larger than the current crisis.Larger FrameChiron in Taurus initiates an era of healing in the domains that matter most for the continuation of life on this planet. The body. The earth. The radical inequality of who has access to sustenance. The severed relationship between human civilization and the living web it depends on.This is the wound beneath many wounds. The one that colonial dominator culture has both created and depended on to sustain itself. Chiron in Taurus will not let it remain invisible.The Summer Solstice opening this era is fitting. The longest light, blessing the beginning of a long healing.Reflection QuestionsWhere in my relationship to body, earth, money, or resource do I sense a wound that has not yet been fully named or witnessed?As Chiron begins its long transit through Taurus, what does genuine healing look like in the domains of physical life, sustenance, and belonging to the earth?On this Solstice threshold, what have I been growing in this half of the year that deserves to be honored in the fullness of this light?Stand at the Solstice threshold before moving on. Feel the earth beneath you. Let the body remember that it belongs to something ancient and reciprocal.We are not only living through breakdown. We are living through the beginning of a healing larger than any of us can fully see from inside it.Podcast poem: Cornwall Swamp by Julie Cadwallader StaubIf this transmission has been useful, share it with someone who might need orientation in these times.Support the showGo to Sheila's website for information for transformational resources: https://www.ontheedgesofchange.comThis episode was co-created with generative AI, engaged as a soul-aligned ally in service of transformation. At the edge where technology meets myth, I choose insight over noise, and alchemy over automation. Thank you for dreaming the future with me.
SpaceX lists today (June 12) and will be followed by two more AI mega-IPOs: OpenAI and Anthropic. Collectively valued at more than $US3.5 trillion, every index fund on the planet will be forced to buy them. Stockspot founder Chris Brycki joins The Australian's Wealth Editor Julie-anne Sprague to discuss whether this is the opportunity of a generation or the most expensive bag-hold in history. The mega float moment: What the SpaceX, OpenAI, and Anthropic listings mean for your portfolio ETFs vs. stock picking in a concentrated market The ASX's innovation gap and why Australian investors can't afford a home-market bias The CGT shake-up and what it means for your investments See omnystudio.com/listener for privacy information.
Allison Morris, Crime Correspondent with the Belfast Telegraph, assesses the potential fallout of the violence in Belfast on Tuesday night.
Jennifer Pierre serves as General Manager of the State Water Contractors (SWC), a statewide nonprofit association representing 27 public water agencies that receive water from California's State Water Project. Collectively, these agencies provide water to more than 27 million Californians and irrigate approximately 750,000 acres of farmland. With more than 20 years of experience in California water policy, Delta management, and water supply planning, Jennifer leads the SWC's efforts to advance reliable, sustainable, and affordable water supplies for communities throughout the state. She is recognized for her commitment to collaboration, science-based decision-making, and balancing water management objectives with environmental stewardship. Prior to joining SWC in 2017, Jennifer spent 14 years with ICF International, where she served as a Principal and led complex water supply, restoration, and planning projects throughout the Sacramento-San Joaquin Delta and its tributaries. Her expertise includes State Water Project and Central Valley Project operations, environmental compliance, ecosystem management, regulatory policy, and stakeholder engagement. Throughout her career, she has successfully guided multidisciplinary teams of engineers, hydrologists, biologists, and policy experts in developing technical analyses, environmental documentation, and water resource solutions. Jennifer earned a Bachelor of Science in Environmental Biology and Management, with an emphasis in Conservation Biology, from the University of California, Davis.
Welcome to the Celestial Insights Podcast, the show that brings the stars down to Earth! Each week, astrologer, coach, and intuitive Celeste Brooks of Astrology by Celeste will be your guide. Her website is astrologybyceleste.com.
Podcasting 2.0 June 5th 2026 Episode 262 - "Podcleanse" Dave and Adam are joined by John Spurlock and throw a big idea into the boardroom: The Podcast Data Collective Shownotes ----------------------------------------------------------------------------------------------------------------------------------------- John Spurlock - Guest The man behind op3.dev and Livewire.io - From the Great State of New Jersey! ----------------------------------------------------------------------------------------------------------------------------------------- 01 - THE IMPRESSION HEIST — AMP TASK FORCE RATIFIES 4 EXPOSURE DEFINITIONS, NO DISSENTING VOTES Podnews press release Jun 4: AMP Task Force Introduces Cross-Platform Alternative to the Podcast "Download" — "unified impression guidance for audio and video, advancing impression-based measurement as the medium's primary transaction currency." Four exposure definitions ratified. JS Jun 4 quote: "the AMP Task Force ratified a new framework with four exposure definitions, with no dissenting votes." Podcast Play: 30 seconds of content played, audio or video, once per user per session. Podcast Audience: The number of unique users who had a Podcast Play. Ad Impression: A commercial begins playing for the user. Ad Audience: The number of users exposed to an Ad Impression. They wanted to 'hasten the demand' Backstory: AMP first emerged May 29 (Podnews) — same day PC20-261 aired — "to confront podcasting's measurement dilemma." @dave reaction Jun 4 16:12: "RE: [Podnews AMP story] More secretive, back room podcast 'industry' nonsense." PNWR Jun 5 confirms the cabal-composition critique — James and Sam open the show debating AMP. James: "they also want to define what an impression is" + "we don't have a definition of podcast." Sam: "I don't think podcasting is [defined], we can measure consumption." PNWR catches the gaps [0:09:00-0:09:30]: "Spotify yes, Acast no, Art19 missing… Apple is already doing that. Apple is already being cut [out]." Same observation @dave made — who's in the room and who isn't. @js replies @dave on AMP Jun 4: "@dave Dave there were no dissenting votes" — Mastodon-thread confirmation that JS + Dave are on the same page about the consensus-by-cabal red flag. Discussion: V4V counter-thesis — No Agenda is value-for-value (no impressions, no exposures). Open standards vs industry cabals. PNWR is independent-podcaster-aligned; AMP is platform-aligned. Podnews AMP Jun 4 press release Podnews AMP origin May 29 @dave Jun 4 reaction post JS Jun 4 quote post PNWR this week (Pod News Weekly Review) ----------------------------------------------------------------------------------------------------------------------------------------- 02 - THE OPEN COUNTERPART — PODCAST INDEX ISSUE #775 (PNWR + @DAVE BOTH ON IT) ----------------------------------------------------------------------------------------------------------------------------------------- 03 - THE WHY BEHIND IMPRESSIONS — "THE FIRST FOUR AND A HALF MINUTES" ----------------------------------------------------------------------------------------------------------------------------------------- 04 - THE PODCASTING 2.0 DATA COLLECTIVE — THE OPEN ANSWER TO AMP The Podcasting 2.0 Data Collective — the open, V4V-aligned answer to the AMP cabal. Not a consortium with ratified definitions and trade-press releases. A collective of open tools and honest sentinels: OP3 for analytics, Podverse + newpodcasts.net for corpus data, Podcast Index for the namespace, Issue #775 for client identification done right. Matthew 5:6 (KJV): "Blessed are they which do hunger and thirst after righteousness: for they shall be filled." The verse that frames the work. Open data, transparent measurement, value-for-value — righteousness in podcast governance. Those who hunger for it are the ones who'll be filled. The AMP cabal trades righteousness for an ad-tech seat at the table; the Data Collective just keeps the lights on. THE CHARTER — Adam's working document, June 5 2026 We hold more power than we give ourselves credit for. Definition of a Podcast: Syndicated delivery of media files with precise consumption data for all stakeholders. What we brought in (the Podcasting 2.0 namespace contributions): Transcripts Chapters Funding (V4V) Person Location …etc. Statistical relevance: Advertising is based on percentages. Collectively we have about 10% of all apps — statistically enough to be relevant. Godcaster app tracing proves we can measure important metrics. Data to aggregate and display: Follows Plays per episode Completion rate by time Strategy: Become the authoritative source by publishing open stats Monetize We will not be loved initially by the industry, because we will have the truth. Advertisers will love us though, as will Podcasters. Monetization: Data subscriptions Resellers (DJL) Ad Networks Podcasters themselves (consideration) Podcast Index has built the trust needed to house this data. We already have a data exchange relationship with the apps. op3.dev is critical in this equation to offset the old system for correlation. OP3 full podcast support landed this week [PNWR 1:53:00-1:54:30] — OP3.dev now has full episode-level + show-level analytics support for podcasts. Spec work also moving on private feeds (insecure feeds spec). Direct relevance to V4V infrastructure. @dave → @james Jun 5 11:50: "Do you have the daily lists that show up on newpodcasts.net available anywhere as a download? I'd love the full, historical list of feed urls that have appeared there if possible." Open-data request — corpus curation theme. @dave → @mitch May 30: "Would you be able to send me a flat list of all the feed urls in Podverse which have more than X number of subscribers/followers? Let's say more than 5?" Podverse data request — corpus quality. Anchor FM RSS restoration request — Fri 11:01 email to NA inbox (Lusso Lets). Listener can't retrieve feed data from Podcast Index. Adjacent infra beat — the unsung user-facing pain of corpus indexing. Discussion: corpus curation as a steady-state job (Dave's sentinel work) vs measurement standards (the AMP cabal) — which one keeps the ecosystem honest? The Data Collective doesn't ratify, it just shows up to maintain. Hunger and thirst. They shall be filled. OP3.dev — open podcast analytics ----------------------------------------------------------------------------------------------------------------------------------------- 05 - CAPTIVATE LAUNCHES DAX US — THE IMPRESSION ECONOMY IRL ----------------------------------------------------------------------------------------------------------------------------------------- 06 - BBC GOES ALL-IN ON CROSSED WIRES YEAR 3 — IPLAYER DEAL + "EDINBURGH OF PODCASTING" ----------------------------------------------------------------------------------------------------------------------------------------- 07 - STREAMING CONSOLIDATION — YOUTUBE MUSIC + TUBI + NETFLIX ALL WANT "PODCAST" ----------------------------------------------------------------------------------------------------------------------------------------- 08 - SUPPLY CHAIN SECURITY — VS CODE DELAYS, PHP FOUNDATION, SLSA LEVEL 3 IS NOT ENOUGH ----------------------------------------------------------------------------------------------------------------------------------------- 09 - AI BUBBLE PC20-FLAVOR — TOTO CHUCKS, MOTHER COMPUTERS, "NO 'I', ONLY MATH" ----------------------------------------------------------------------------------------------------------------------------------------- 10 - QUIPS / TRANSITIONS ----------------------------------------------------------------------------------------------------------------------------------------- Last Modified 06/05/2026 14:38:09 by Freedom Controller
Podcasting 2.0 June 5th 2026 Episode 262 - "Podcleanse" Dave and Adam are joined by John Spurlock and throw a big idea into the boardroom: The Podcast Data Collective Shownotes ----------------------------------------------------------------------------------------------------------------------------------------- John Spurlock - Guest The man behind op3.dev and Livewire.io - From the Great State of New Jersey! ----------------------------------------------------------------------------------------------------------------------------------------- 01 - THE IMPRESSION HEIST — AMP TASK FORCE RATIFIES 4 EXPOSURE DEFINITIONS, NO DISSENTING VOTES Podnews press release Jun 4: AMP Task Force Introduces Cross-Platform Alternative to the Podcast "Download" — "unified impression guidance for audio and video, advancing impression-based measurement as the medium's primary transaction currency." Four exposure definitions ratified. JS Jun 4 quote: "the AMP Task Force ratified a new framework with four exposure definitions, with no dissenting votes." Podcast Play: 30 seconds of content played, audio or video, once per user per session. Podcast Audience: The number of unique users who had a Podcast Play. Ad Impression: A commercial begins playing for the user. Ad Audience: The number of users exposed to an Ad Impression. They wanted to 'hasten the demand' Backstory: AMP first emerged May 29 (Podnews) — same day PC20-261 aired — "to confront podcasting's measurement dilemma." @dave reaction Jun 4 16:12: "RE: [Podnews AMP story] More secretive, back room podcast 'industry' nonsense." PNWR Jun 5 confirms the cabal-composition critique — James and Sam open the show debating AMP. James: "they also want to define what an impression is" + "we don't have a definition of podcast." Sam: "I don't think podcasting is [defined], we can measure consumption." PNWR catches the gaps [0:09:00-0:09:30]: "Spotify yes, Acast no, Art19 missing… Apple is already doing that. Apple is already being cut [out]." Same observation @dave made — who's in the room and who isn't. @js replies @dave on AMP Jun 4: "@dave Dave there were no dissenting votes" — Mastodon-thread confirmation that JS + Dave are on the same page about the consensus-by-cabal red flag. Discussion: V4V counter-thesis — No Agenda is value-for-value (no impressions, no exposures). Open standards vs industry cabals. PNWR is independent-podcaster-aligned; AMP is platform-aligned. Podnews AMP Jun 4 press release Podnews AMP origin May 29 @dave Jun 4 reaction post JS Jun 4 quote post PNWR this week (Pod News Weekly Review) ----------------------------------------------------------------------------------------------------------------------------------------- 02 - THE OPEN COUNTERPART — PODCAST INDEX ISSUE #775 (PNWR + @DAVE BOTH ON IT) ----------------------------------------------------------------------------------------------------------------------------------------- 03 - THE WHY BEHIND IMPRESSIONS — "THE FIRST FOUR AND A HALF MINUTES" ----------------------------------------------------------------------------------------------------------------------------------------- 04 - THE PODCASTING 2.0 DATA COLLECTIVE — THE OPEN ANSWER TO AMP The Podcasting 2.0 Data Collective — the open, V4V-aligned answer to the AMP cabal. Not a consortium with ratified definitions and trade-press releases. A collective of open tools and honest sentinels: OP3 for analytics, Podverse + newpodcasts.net for corpus data, Podcast Index for the namespace, Issue #775 for client identification done right. Matthew 5:6 (KJV): "Blessed are they which do hunger and thirst after righteousness: for they shall be filled." The verse that frames the work. Open data, transparent measurement, value-for-value — righteousness in podcast governance. Those who hunger for it are the ones who'll be filled. The AMP cabal trades righteousness for an ad-tech seat at the table; the Data Collective just keeps the lights on. THE CHARTER — Adam's working document, June 5 2026 We hold more power than we give ourselves credit for. Definition of a Podcast: Syndicated delivery of media files with precise consumption data for all stakeholders. What we brought in (the Podcasting 2.0 namespace contributions): Transcripts Chapters Funding (V4V) Person Location …etc. Statistical relevance: Advertising is based on percentages. Collectively we have about 10% of all apps — statistically enough to be relevant. Godcaster app tracing proves we can measure important metrics. Data to aggregate and display: Follows Plays per episode Completion rate by time Strategy: Become the authoritative source by publishing open stats Monetize We will not be loved initially by the industry, because we will have the truth. Advertisers will love us though, as will Podcasters. Monetization: Data subscriptions Resellers (DJL) Ad Networks Podcasters themselves (consideration) Podcast Index has built the trust needed to house this data. We already have a data exchange relationship with the apps. op3.dev is critical in this equation to offset the old system for correlation. OP3 full podcast support landed this week [PNWR 1:53:00-1:54:30] — OP3.dev now has full episode-level + show-level analytics support for podcasts. Spec work also moving on private feeds (insecure feeds spec). Direct relevance to V4V infrastructure. @dave → @james Jun 5 11:50: "Do you have the daily lists that show up on newpodcasts.net available anywhere as a download? I'd love the full, historical list of feed urls that have appeared there if possible." Open-data request — corpus curation theme. @dave → @mitch May 30: "Would you be able to send me a flat list of all the feed urls in Podverse which have more than X number of subscribers/followers? Let's say more than 5?" Podverse data request — corpus quality. Anchor FM RSS restoration request — Fri 11:01 email to NA inbox (Lusso Lets). Listener can't retrieve feed data from Podcast Index. Adjacent infra beat — the unsung user-facing pain of corpus indexing. Discussion: corpus curation as a steady-state job (Dave's sentinel work) vs measurement standards (the AMP cabal) — which one keeps the ecosystem honest? The Data Collective doesn't ratify, it just shows up to maintain. Hunger and thirst. They shall be filled. OP3.dev — open podcast analytics ----------------------------------------------------------------------------------------------------------------------------------------- 05 - CAPTIVATE LAUNCHES DAX US — THE IMPRESSION ECONOMY IRL ----------------------------------------------------------------------------------------------------------------------------------------- 06 - BBC GOES ALL-IN ON CROSSED WIRES YEAR 3 — IPLAYER DEAL + "EDINBURGH OF PODCASTING" ----------------------------------------------------------------------------------------------------------------------------------------- 07 - STREAMING CONSOLIDATION — YOUTUBE MUSIC + TUBI + NETFLIX ALL WANT "PODCAST" ----------------------------------------------------------------------------------------------------------------------------------------- 08 - SUPPLY CHAIN SECURITY — VS CODE DELAYS, PHP FOUNDATION, SLSA LEVEL 3 IS NOT ENOUGH ----------------------------------------------------------------------------------------------------------------------------------------- 09 - AI BUBBLE PC20-FLAVOR — TOTO CHUCKS, MOTHER COMPUTERS, "NO 'I', ONLY MATH" ----------------------------------------------------------------------------------------------------------------------------------------- 10 - QUIPS / TRANSITIONS ----------------------------------------------------------------------------------------------------------------------------------------- Last Modified 06/05/2026 14:38:09 by Freedom Controller
today we explore the transformative role of artificial intelligence in modern space exploration and astronomical research. Scientists are currently utilizing machine learning algorithms to process vast quantities of data from telescopes, significantly accelerating the identification of celestial objects and potential extraterrestrial signals. Beyond data analysis, autonomous AI systems are being integrated into off-Earth missions to handle real-time navigation and the prediction of hazardous solar flares. On the International Space Station, interactive technology like CIMON serves as a hands-free assistant to improve astronaut efficiency during complex experiments. Collectively, these texts highlight how AI acts as a vital partner in overcoming the physical and computational challenges of deep space discovery.
today we examine the legal, economic, and ethical landscapes of artificial intelligence as it integrates into global society. They highlight active regulatory efforts like the EU AI Act and the U.S. Algorithmic Accountability Act, alongside international agreements focused on frontier AI safety and corporate responsibility. Economic analysis from the collection indicates that AI is already reshaping the labor market, specifically impacting white-collar sectors and shifting the risks for high-wage occupations. Expert reports clarify that U.S. tort law and liability frameworks will increasingly govern AI-related harms, even as debates persist regarding the security trade-offs between open-source and closed-source models. Furthermore, the documents emphasize the necessity of protecting consumer privacy and implementing inclusive engagement practices to prevent systemic bias. Collectively, these materials provide a comprehensive overview of how governments and industries are attempting to balance rapid innovation with public safety and accountability
Dr. Julie Radlauer joins Something For Everybody this week. Dr. Julie is a leading expert in behavioral health, international keynote speaker, founder of Collectively, a TEDx speaker, and a best-selling author of CONNECT. Dr. Julie shares her perspectives on mental health, resilience, social influences, and how to build a supportive community. She discusses practical tools for improving mental well-being, the importance of authenticity, and how young people can navigate life's challenges with confidence. -
Link to Journal Entries A Guide to Almost Everything https://youtu.be/ONc03wC1zFA Thumbnail: Silent AP Failures or Hidden AP Failures The Costs You Miss Stop the Bleeding Your company is losing money right now — and no one can see it happening. Not leadership. Not procurement. Not even finance. But Accounts Payable can. Because the truth is this: most organizations don't bleed money through big, dramatic failures. They bleed through the tiny, invisible cracks in their AP fundamentals — the ones no one ever talks about because they seem “too basic” to matter. But those basics? They're exactly where the damage starts. A missing invoice. A coding error. A rushed approval. A vendor setup shortcut. A “temporary” workaround that somehow becomes permanent. Individually, they look harmless. Collectively, they create duplicate payments, late fees, vendor escalations, audit findings, strained relationships, and real financial leakage — all happening quietly in the background while everyone assumes AP is “just processing invoices.” Today, I'm pulling back the curtain on the AP fundamentals that silently cost companies thousands — sometimes millions — every year. And by the end of this video, you'll know exactly which basics your organization is overlooking… AND how to stop the bleeding before it becomes a crisis.
Welcome to the Celestial Insights Podcast, the show that brings the stars down to Earth! Each week, astrologer, coach, and intuitive Celeste Brooks of Astrology by Celeste will be your guide. Her website is astrologybyceleste.com.
Tesla's autonomous driving initiatives, highlighting a sharp divide between corporate goals and operational realities. While Elon Musk continues to promise that unsupervised Full Self-Driving (FSD) will soon achieve superhuman safety, the National Highway Traffic Safety Administration (NHTSA) has escalated a major probe into the system's failure to handle low-visibility conditions. Regional Robotaxi pilots in Texas are currently facing significant logistical hurdles, including long wait times and a shrinking active fleet despite recent expansions. Furthermore, investigative reports suggest that Tesla's safety statistics may be methodologically flawed, while European regulators remain skeptical of the technology's performance on icy roads and at high speeds. Collectively, these documents portray a company aggressively pivoting toward AI and robotics while navigating intense legal, regulatory, and technical challenges.
we investigate the functional limitations, environmental costs, and security vulnerabilities inherent in modern artificial intelligence and the Transformer architecture. Research from MIT and various technical papers highlights how AI faces "model collapse" when trained on synthetic data, as well as "catastrophic forgetting" where new information causes the system to lose prior knowledge. Mathematical analyses demonstrate that Transformers struggle with function composition and complex logic, often leading to factual hallucinations and reasoning errors. Furthermore, the texts identify prompt injection attacks as a significant security risk, where malicious instructions can bypass safety guardrails to leak data or spread misinformation. Collectively, the documents suggest that while AI is transformative, it remains constrained by technical bottlenecks, reliability issues, and high resource consumption. Efforts toward achieving Artificial General Intelligence must therefore overcome these fundamental obstacles through better data quality and enhanced architectural robustness.
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. The landscape of these industries continues to evolve with significant scientific advancements, regulatory breakthroughs, and strategic maneuvers that are reshaping drug development and patient care. One of the noteworthy developments is the U.S. FDA's recent approval of Gilead Sciences' Hepcludex (bulevirtide) for hepatitis D. This approval marks a comeback for Gilead after previous setbacks due to manufacturing and delivery issues, highlighting the critical importance of addressing regulatory feedback. It's a testament to persistence in overcoming manufacturing challenges to ensure vital therapies reach those in need. This approval signifies a milestone as it's the first FDA-approved therapy targeting chronic hepatitis D virus infection—a niche condition with limited treatment options. Similarly, Pfizer's Braftovi (encorafenib) is expanding its global reach beyond U.S. borders with regulatory approvals in the EU and Canada for colorectal cancer treatment. This broadening geographic footprint reflects a broader industry trend where companies aim to maximize the therapeutic impact of oncology drugs across diverse patient populations. Meanwhile, Astellas Pharma is navigating the looming patent cliff for its prostate cancer drug Xtandi by actively pursuing new licensing deals and implementing cost-cutting measures. This dual approach underscores a widespread industry strategy where companies balance acquisitions with operational efficiency to sustain growth. In the radiopharmaceutical sector, there's notable activity with Lantheus Holdings possibly being acquired by Curium for $7 billion. This potential deal underscores growing interest in radiopharmaceuticals due to their precision in targeting specific cancer types. Complementing this is Niowave's $75 million investment in a radiopharmaceutical isotope plant in Michigan, set to produce actinium-225 by 2028—an isotope crucial for targeted cancer therapies. Regulatory landscapes are also in flux with continued reforms at the FDA despite leadership changes. Initiatives like the Commissioner's National Priority Voucher program illustrate regulatory bodies' commitment to streamlining drug approvals and fostering innovation. On an international note, SK Bioscience is partnering with Colombia to locally produce the chickenpox vaccine Skyvaricella, enhancing vaccine accessibility through technology transfer. Similarly, Eli Lilly's acquisition spree in infectious disease research signals a robust push toward expanding its R&D pipeline for viral and bacterial pathogens. Eli Lilly has announced plans to acquire Curevo, Limmatech Biologics, and another vaccine company for up to $3.8 billion. This strategic acquisition underscores a commitment to enhancing capabilities in infectious diseases—a field that has gained focus post-COVID-19 pandemic. By integrating these companies, Eli Lilly aims to leverage their platforms and expertise for advanced therapeutic solutions against infectious diseases. In gene editing, Eli Lilly is preparing for a Phase 2 trial of a lipid-lowering gene editor from Verve Therapeutics, showing promising cholesterol reductions akin to PCSK9 inhibitors. This highlights gene editing's potential in addressing cardiovascular diseases. A significant development from Lilly's pipeline includes promising results from their base editor technology acquired through Verve Therapeutics—an exciting breakthrough suggesting substantial potential for gene-editing technologies addressing genetic disorders like high cholesterol. In oncology, AstraZeneca and Daiichi Sankyo's Datroway gained FDA approval for triple-negative breast cancer as a first-line treatment. This antibody-drug conjugate targets Trop2, demonstrating the potential of targeted therapy in difficult-to-treat cancers. Kura Oncology's combination therapy featuring darlifarnib and Krazati showed up to a 69% response rate in KRAS G12C-mutated solid tumors during Phase 1 trials, emphasizing precision medicine's potential in targeting specific genetic mutations driving cancer progression. In obesity management, Eli Lilly's retatrutide achieved Phase 3 success with bariatric surgery-like outcomes. The drug acts as a triple hormone receptor agonist, showcasing advancements in metabolic therapies targeting obesity—a condition linked with numerous comorbidities. Moderna's mFlusiva is poised for an FDA advisory committee review as an influenza preventative for older adults—an extension of Moderna's mRNA technology initially used against COVID-19. Collectively, these developments highlight an industry leveraging cutting-edge science and technology to tackle complex medical challenges. As pharmaceutical giants like Eli Lilly consolidate their positions through acquisitions and research collaborations, transformative advancements promise to reshape patient care across various therapeutic areas. These initiatives not only reflect the industry's dynamic nature but also its pivotal role in addressing unmet medical needs worldwide. Eli Lilly's recent strategic acquisitions underscore its commitment to advancing pharmaceutical innovations, particularly in vaccines and cholesterol management sectors. Acquiring three vaccine-focused biotech firms signifies substantial investment in expanding its vaccine portfolio—a move aligned with global immunization strategies. This follows hiring Peter Marks from the FDA, indicating a strategic focus on bolstering expertise within the vaccine domain. The company has been recognized by IDEA Pharma as a leader in pharmaceutical innovation—a testament to its robust pipeline and successful integration of scientific advancements into marketable therapies. Across oncology landscapes highlighted at ASCO conferences are exciting potentials like Summit Therapeutics and Akeso's potential Keytruda rivals that could reshape cancer treatment paradigms if proven effective. As pharmaceutical landscapes continue evolving rapidly through scientific strides tempered by regulatory hurdles—the current environment promises significant advancements offering new hope while demanding strategic agility within healthcare sectors globally.Support the show
A draft class searching for traction The Detroit Lions Podcast put the 2024 draft class under a harsh light. Two years in, the group has flashed but not finished. The Detroit Lions need more in the NFL's tight margins. This feels like a prove-it season for the entire class, headlined by first-round pick Terryon Arnold at No. 24 overall after a trade up with Dallas from 28. Terryon Arnold needs consistent CB1 tape Arnold has shown it in stretches. Early last year he looked the part outside. Midseason he matured. He played less handsy. He read the receiver better. Then came the injury. Then penalties. Then a general lack of effectiveness. He has not played like a first-rounder yet. The expectation remains that he opens 2026 as a starting outside cornerback. The benefit of the doubt is fading. He has one more season before the fifth-year option decision becomes straightforward or complicated. The Dallas trade context matters Detroit paid a first and a third to move up for Arnold. Those Dallas picks turned into Tyler Guyton and Cooper Beebe. Guyton has started at tackle and shown an inconsistent but impressive profile. Beebe has started at center and been decent, short of high expectations. No one knows if the Lions would have made the same choices. They did spend time with Beebe at the Senior Bowl. Viewed through that prism, the move has not produced the intended return yet in Detroit. Ennis Rakestraw's availability and a crowded slot Rakestraw has played eight games in two years. Multiple injuries hit both seasons, echoing a college pattern where timing hurt his offseasons more than his Saturdays. This is a big year for him. The room around him has tightened. Detroit drafted Keith Abney in that spot and signed Roger McCreery there. Christian Risdon and Avante Maddox can play slot nickel. Outside, they brought Brockus back. Nick Whiteside is back, and to this point he has shown more in coverage than Rakestraw. The challenge is clear. Day 3 pieces still seeking a spark Giovanni Manu arrived as an offensive lineman from British Columbia in the fourth. Also in the fourth, Vaki was listed as a safety at Utah but Detroit drafted him to play running back, a role he handled at Utah and at the Senior Bowl. In the sixth, Mangin Wingo came in at defensive tackle from LSU. The Lions also added guard Chris Mahogany from Boston College. Collectively, the group has been underwhelming and frustrating. There is time, but not much, for this class to match the standard set elsewhere on the roster. The 2026 tape has to change the story. #detroitlions #lions #detroitlionspodcast #terrionarnold #ennisrakestraw #giovannimanu #2024nfldraft #mekhiwingo #christianmahogany #sionevaki Learn more about your ad choices. Visit megaphone.fm/adchoices
Welcome to the Celestial Insights Podcast, the show that brings the stars down to Earth! Each week, astrologer, coach, and intuitive Celeste Brooks of Astrology by Celeste will be your guide. Her website is astrologybyceleste.com.
Where Is Your Source of Genuine Meaning?This week the pressure deepens.It opens on Memorial Day in the United States, a moment when a nation is asked to honor its dead, even as it struggles to honestly name what so many of them died for, and what continues to be sacrificed in the service of systems that were never designed for everyone.An Elder perspective (which we can all carry) does not bypass that tension. It holds it.Key Cycles This Week:Monday, May 25: Mars in Taurus squares Pluto in Aquarius. Memorial Day. A confrontation between force and transformation. Where your will or resources meet something that does not yield easily, this is not a transit to push through with more force. Stay grounded. Feel where your actual resources are. Resist the pull toward reaction in a week that will offer plenty of provocation.Collectively, this transit on Memorial Day carries particular weight. The structures of power being challenged right now were built on specific choices, specific violence, specific mythologies of superiority. That is not abstract history. It is present architecture.Tuesday, May 26: Sun in Gemini trines Pluto in Aquarius. A day later, tension eases into something more workable. What felt like confrontation yesterday may begin to reveal its deeper pattern. A good moment for clarity, for seeing beneath the surface with less distortion and more genuine perception.Thursday, May 28: Venus in Cancer squares Saturn in Aries. The Relational One in the nurturing sign of Cancer meets the Structurer, and it is not an easy meeting. This transit carries a deeper archetypal current worth naming. Venus represents the feminine principle, relational and attuned to what nourishes connection. Saturn in its wounded expression becomes external authority that restricts and defines what the feminine is permitted to be or decide.This is the oldest survival pattern many have inherited, the feminine adapting and deferring under systems never designed to hold her sovereign. We are watching that pattern in its most literal form right now, in the ongoing legislative assault on women's autonomy and rights. This transit asks where in your own life you have been running on adaptation rather than authentic choice. That clarity, even if tender, is more useful than the blur.Sunday, May 31: Full Moon at 10 degrees of Sagittarius and Mercury in Gemini sextiles Chiron in Aries. The Full Moon illuminates the Gemini-Sagittarius axis, the axis of information and meaning. Gemini gathers data. Sagittarius asks what it means and what larger truth it serves. In a time when information is being generated and weaponized at unprecedented scale, this lunation asks where your source of genuine meaning actually is. Not what you have been told to believe, but what in your own deeper knowing actually orients you.Mercury sextiling Chiron weaves in the wounded healer thread. Something that has needed to be said may find its moment here.Larger FrameThis week moves from confrontation to clarity to limitation to illumination. What is being asked is a particular kind of maturity. To stay present to what is difficult without collapsing into it. To be honest about relational limitation without abandoning the longing for genuine care. To locate ourselves not in the information stream, which is vast and often deliberately disorienting, but in genuine meaning.That is always the Elder's work. To hold the longer view when immediate pressure makes the longer view feel impossible.Reflection QuestionsWhere am I being asked to meet something immovable this week, and what does genuine power look like in that encounter, as distinct from force or reaction?In my relational field, where am I being called to greater honesty about what is genuinely nourishing versus what has been running on adaptation rather than authentic choice?Beneath the volume and speed of the current information field, what actually orients me? What is my source of genuine meaning?This is a week that asks for groundedness more than brilliance. You do not have to have answers. You are asked only to stay present to what is real, resist the pull toward reaction, and keep returning to what genuinely orients you.The web of life holds more than the current noise suggests.Podcast poem: How Surely Gravity's Law by Rainer Maria RilkeIf this transmission has been useful, share it with someone who might need orientation in these times.Support the showGo to Sheila's website for information for transformational resources: https://www.ontheedgesofchange.comThis episode was co-created with generative AI, engaged as a soul-aligned ally in service of transformation. At the edge where technology meets myth, I choose insight over noise, and alchemy over automation. Thank you for dreaming the future with me.
Today marks 1,993 years since Pentecost, when the Holy Spirit birthed the church and solved humanity's two greatest problems. The Eden problem created separation from God through sin, which Jesus resolved through His birth, death, and resurrection. The Babel problem created separation between people through scattered languages and division, which the Holy Spirit solved at Pentecost by uniting all believers under one Spirit with one purpose. God had promised this solution through Ezekiel and Jeremiah, offering new hearts and a new covenant written on our hearts. The Holy Spirit is another of the same kind as Jesus, and every believer receives the complete Spirit. Collectively, we are being built together as God's dwelling place, worshiping and using our gifts to strengthen the whole church. Individually, the Spirit gives us faith, testifies that we belong to God, and seals us as His own.
Jump into Talk Cosmos: "URANUS SEDNA 01° GEMINI VIBRATIONS"Join us on Sunday, May 24, from 1–2 p.m. PDT with Linda Berry and Robert Pacitti unraveling Vibrational Astrology revelations about the extraordinary conjunction between Uranus and outer limit Dwarf Planet Sedna at 01° Gemini (from Earth's viewpoint). Uranus like a master architect through innovation and disruption confers with Sedna, the ‘deepest reservoir of ancestral memory'. Uniquely individual, Uranus interrupts the norm of the solar planets by spinning on its side east to west and rotating backward unlike the other planets. Venus also rotates backwards – but its axis remains north and south similar to all the other planets. However, Sedna orbits at a vast distance in deep interstellar space of the Inner Oort Cloud surrounding our solar system planets. Its extreme elliptical path takes 11,406 years to orbit the Sun. Effectively in the “deep freeze” far beyond the Kuiper Belt.History reveals Uranus as energetically awakening her celestial partnerships. The path may storm at first like lightning in stormy times. Yet overtime circumstances bring new awareness, shifting towards a better experience for humanity. Sedna sprints through Gemini the quickest in only 42-45 years, compared to over a 1000 in Sagittarius. Sedna's last transit in Gemini was when Earth transited out of the Younger Dryas at the end of the last ice age. Changing environment forced migrations. reshaping new communication and network methods humanity learned.This threshold merges with a multitude of several unusual and long cycles, interweaving with Uranus and Sedna. Collectively impacting Uranus or Sedna. What more could be resting in Sedna's hidden realms for us to realize? We are aware technology leaps with AI – reducing global distances as an immediate relationship. Connecting with remote parts of the world can promote understanding by having empathy.About Vibrational Astrology (VA): VA is an exciting ‘evidence-based' system focusing on deep energetic vibrational frequency behavior patterns far within and beyond the natal chart.LINDA BERRY, PAC, MSSW: received her Professional Astrology Certificate (PAC) in Vibrational Astrology January 2015 from Avalon School of Astrology studying with David Cochrane the Founder of Vibrational Astrology (VA). They continue to share their research material to build Vibrational Astrology knowledge. Linda created “Frequency Finder”, a VA Add-on to Sirius and Kepler Astrological Software.Linda's an International Consultant with clients worldwide, Teaches VA classes, the VA Research Group Moderator, and Author. Website: Astrosleuth.org | Fractal Cosmos Vibrational Astrology Conference - Annual. Website: fractalcosmos.comHer free Daily Blog: “The Vibrational Astrology Diary” Vibrational Astrology & Sabian Symbols, and for a paid Personalized Monthly Report. email: Linda @ AstrologicalDepth dot com.ROBERT PACITTI: Professional consulting astrologer; visionary behind Deep Earth Astrology. Specializing in vibrational and psychological techniques. Over a decade of experience in the world of natural magic. Grand Pendragon in the Ancient Order of Druids in America & Director of the MAGUS Druid Gathering in Gore, VA. Co-Director of the Fractal Cosmos Vibrational Astrology Conference. Faculty for the Centre for Relationships and Astrology. Consultations focus, Archetypal & Harmonic.Email: deepearthastrology@gmail.com. Website: deepearthastrology.com | Facebook.com/SacredConnections13; Facebook.com/rjpacitti fractalcosmos.org SUE ‘ROSE' MINAHAN: Evolutionary Astrologer & Consultant. Speaker, Writer. Student of Vibrational Astrology with Linda Berry, Dwarf Planet University graduate, Kepler Astrologer Toastmaster (KAT); Founder of Talk Cosmos since April 7, 2018. Weekly conversations awaken heart and soul consciousness, TalkCosmos.com | YouTube.com/@TALKCOSMOS.#Uranus #Gemini #Sedna #dwarfplanet #saturnneptunearies #VibrationalAstrology #astrology2026 #talkcosmos #lindaberry #astroslueth #RobertPacitti #SueMinahan #deepearthastrology #newconsciousnessSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
WBSRocks: Business Growth with ERP and Digital Transformation
Send us Fan MailRecent announcements across the enterprise software landscape highlight an accelerating convergence of AI, integration, and industry-specific innovation as core pillars of modern enterprise architecture. Oracle continues to expand its footprint with new capabilities across financial services, process manufacturing, and AI agents embedded within Oracle Fusion Cloud, reinforcing the shift toward intelligent, industry-aware ERP ecosystems. At the same time, Sage is advancing AI-driven enhancements in Sage X3, while NetSuite is strengthening composability through its new integration platform. Beyond core ERP, ecosystem players such as ActiveCampaign, Bombora, and Omilia are embedding intelligence into customer engagement and data workflows, while emerging innovators like Fibr AI attract funding to push experimentation at the edge. Strategic partnerships, including QAD and Tata Consultancy Services, further signal the importance of services-led transformation. Collectively, these moves reflect a broader structural trend: enterprise platforms are evolving into tightly integrated, AI-augmented ecosystems where domain specialization, real-time intelligence, and composable architectures define competitive advantage.In today's episode, we invited a panel of industry analysts for a live discussion on LinkedIn to analyze current enterprise software stories. We covered many grounds, including the direction and roadmaps of each enterprise software vendor. Finally, we analyzed future trends and how they might shape the enterprise software industry.Video: https://www.youtube.com/watch?v=HtcFOMAANWMQuestions for Panelists?
In today's episode of Open Your Eyes, McKay guides listeners through a thought-provoking exploration of the criteria by which we measure our lives. Combining an analysis of lives spectacularly well-lived with his own learnings and sage observations, our host demonstrates the critical importance of ensuring these criteria are firmly founded upon those aspects in life that truly matter.The episode traverses various inspiring narratives, from Dr. Sanduk Ruit's revolutionary work in making cataract surgery affordable for millions in Nepal to Dashrath Manjhi's 22-year mission to carve a safer path through the mountains for his village. McKay also reflects on his battle with cancer, his children's perseverance and relentless determination, and the poignant story of a colleague and his son who was born with severe physical challenges. The episode concludes by drawing on the biblical story of Peter walking on water, underscoring the importance of maintaining faith amidst adversity. Collectively, these stories challenge listeners to consider the legacies they wish to create, ultimately posing the essential question: "How will you measure your life?"Episode Highlights:Global listener reachDr. Sanduk Ruit's journeyDashrath Manjhi's dedicationClayton Christensen on life's measuresPersonal growth through serviceStories highlighting the power of love and perseveranceFaith and overcoming doubtsMeasuring your life by what really matters mostQuotes:"I committed myself to a mission of making eye surgery affordable and accessible to every person in Nepal.""One can measure the surgeries provided to the impoverished in Nepal and the miles of travel saved by Dashrath's new mountain path.""Consider if, ultimately, we are measured against the things that truly matter.""I realized my life would be measured by how I aided people in similar circumstances to mine.""Each day presents a choice on where to place your focus.""Love empowers you to focus, care, and exert more effort.""Keep going until you achieve your goals.""Faith means to believe without seeing, and the reward of faith is to see what you have believed."Links:https://www.mckaychristensen.org/
Join us this week as Donny and Noble join us to discuss what they think about the slow drip feed of content and communication from Bungie and jump in on the whole Marathon/Destiny 2 discussion and debate. We also go over the smallest This Week in Destiny for May 14th 2026 and Peroty keeps you on your toes with the latest copy & paste support report. Nitedemon has what's happening for week 25's rotations. Plus a few things to recommend you check out. 00:01:50 - Welcome to Marathon Talk… and Destiny I suppose 01:04:10 - TWAB Moan & Distraction 01:06:53 - This Week At Bungie: May 14th 2026 01:09:19 - Commanders Orders Complete 01:10:04 - More Emblems 01:17:01 - Activities This Week 01:18:38 - Peroty's Player Support Report 01:20:47- End of the TWAB 01:22:17 - This Week In Destiny: Renegades Rotations Week 25 01:25:46 - No News? 01:34:22 - Video Recommendations 01:37:05 - Patreon Thanks & End of the Show 01:40:46 - Fin Two Titans and a Hunter YouTube Channel Two Titans and a Hunter Twitch Two Titans and a Hunter Discord Two Titans and a Hunter - Patreon Two Titans and a Hunter Ko-Fi The100 io – GH/GD/2TAAH Group Email: twotitansandahunter@hotmail.com Two Titans and a Hunter Twitter Two Titans and a Hunter – Facebook Artwork by @Nitedemon Xbox Live: Nitedemon, & Peroty End credits theme song by Elsewhere - YouTube Channel Plus as always, thank you to Alexander at Orange Free Sounds & www.freesound.org for all the sound effects used in our podcast. Required Stuff: Bungie - This Week at Bungie May 14th 2026 Duqk - Keplar loot Farm Location Duqk - Making Builds Is Easy, Knowing Where To Use Them Is Not Llama - Complete June Update Breakdown Chablo 91 - YouTube Channel Destiny 2 - Tier 5 Report Destiny 2 Armor 2.0 Cleaner Destiny 2 - Way Back Machine Link Twitch - GuardianDownBot Raid Checkpoints Twitch - IceBreakerCatty. Engram.Blue Link
Welcome to the Celestial Insights Podcast, the show that brings the stars down to Earth! Each week, astrologer, coach, and intuitive Celeste Brooks of Astrology by Celeste will be your guide. Her website is astrologybyceleste.com.
This week we highlight the multifaceted global impact of AI infrastructure and digital security, focusing on the physical and financial costs of technological expansion. Reports detail how massive data centers are straining public utilities, causing power disputes in Kenya and Maryland while leading to significant water waste in Georgia. In the realm of cybersecurity, researchers have identified critical vulnerabilities in smart home devices and "zero-day" exploits developed by artificial intelligence, prompting tech giants like Google and Apple to implement stricter protections. Meanwhile, the professional landscape is shifting as Amazon and Nvidia emphasize AI-driven metrics and proprietary software ecosystems, creating new pressures for employees and developers alike. Collectively, these narratives illustrate that while AI offers advancements in molecule design and medical research, its integration into daily life demands greater transparency and more robust infrastructure management.
today we examine the multifaceted challenges and rapid growth of artificial intelligence, focusing on its ethical, social, and technical risks. One major theme is the emergence of AI hallucinations, which are identified as a unique form of misinformation that lacks human intent but threatens the accuracy of public knowledge. The sources also highlight rising concerns regarding algorithmic bias, the environmental impact of large models, and the labor practices involved in data labeling. To address these issues, UNESCO has established a global framework of values and principles designed to promote transparency, accountability, and fairness. Collectively, the texts emphasize that as venture capital investment in generative AI surges, society must develop robust regulatory standards and improved digital literacy to ensure responsible innovation.
The development of next-generation positioning, navigation, and timing (PNT) systems to supplement or replace the aging Global Positioning System (GPS). SpaceX has formally proposed using its Starlink satellite constellation to provide low-Earth orbit (LEO) navigation services, highlighting its potential for resilient, high-bandwidth connectivity that functions independently of traditional military-run signals. Academic research and technical reports further examine how signals of opportunity from various private satellite networks can be harnessed to improve accuracy and spoofing resistance for drones and maritime vessels. While these innovations offer a robust backup against electronic warfare, some experts express concerns regarding system privatization and the potential for subscription-based access fees. Technical simulations reveal that satellite trajectory accuracy and geographic latitude remain critical factors in determining the reliability of these emerging space-based navigation alternatives. Collectively, the documents advocate for a diversified PNT ecosystem to ensure global security and economic stability.
Andy Ramage is a former professional footballer who, following a career-ending injury, went on to establish two successful financial brokerages.After taking a transformative break from alcohol, Andy experienced profound changes in his mind, body, career, and overall life. Now, a decade later, he is widely regarded as one of the world's leading alcohol-free performance coaches.Andy is the best-selling author of The 28-Day Alcohol-Free Challenge and Let's Do This! How to Use Motivational Psychology to Change Your Habits for Life. His influential TEDx talk, The Limitless Pill, has inspired countless individuals to unlock their full potential.A dynamic speaker, Andy has shared his insights on some of the world's biggest stages and top podcasts, including The Rich Roll Podcast, Feel Better, Live More with Dr Rangan Chatterjee, The Slo Mo Podcast with Mo Gawdat, and The Virgin Radio Breakfast Show with Chris Evans.As the original founder of the OneYearNoBeer (OYNB) movement, Andy helped pioneer the alcohol-free revolution. After leaving OYNB in 2019, he created The Willpower-Free Method ™ to quit alcohol easily & rapidly. Collectively, these initiatives have helped hundreds of thousands—if not millions—of people improve their health, performance, and happiness by taking a break from alcohol.Andy is in an elite group of coaches trained to the master's degree level in coaching psychology and positive psychology. He works with clients at every level, from everyday heroes to premiership footballers and C-suite executives.Andy also serves as a lead trainer at the Professional Footballers' Association (PFA) Business School.Andy is also the founder of Coach Business School, which turns novices into world-class coaches through its coach accreditation courses and helps accredited coaches achieve their business goals through Andy's unique Coach MBA. In addition to his coaching work, Andy is producing a groundbreaking documentary ‘Going Dry' —set for release in summer 2026—that aims to be the alcohol-free equivalent of The Game Changers, shining a spotlight on the benefits of an alcohol-free lifestyle. Hosted on Acast. See acast.com/privacy for more information.
Welcome to a special series of Art Pays Me interviews with the winners of the 2025 Creative Nova Scotia Awards. Presented annually by Arts Nova Scotia and the Creative Nova Scotia Leadership Council, these awards celebrate artistic excellence across Mi'kma'ki. Award categories are as follows: Creative Community Impact Prix Grand-Pré Established Artist Emerging Artist Black Artist Indigenous Artist And finally, The Portia White Prize that is given to a person who has made outstanding and significant contributions to Nova Scotia's creative community over a sustained career – much like the incredible woman that the award is named after. The winner will also choose a protege, an emerging artist or cultural organization that will also receive funding. Collectively, the awards are worth $75,000! Visit artsns.ca for more information. This series would not be possible without the fantastic production work of Heist and Keke Beatz. artpaysme.com About Nicola Saxophonist and Composer Nicola Miller (she/her) is based on the South Shore of Nova Scotia, where she has become a vital part of the maritime creative music ecosystem. Weaving endless sonic curiosity into a jazz foundation, the music she plays and writes effortlessly traverses boundaries of style and approach. Miller has appeared in performances alongside a diverse cross-section of artists including Nicole Rampersaud, Charlotte Hüg, Terri Hron, India Gailey, Enrique Luna, Sam Wilson, Uri Caine, Tim Crofts, Glenn Patscha, and Nick Halley. She's been featured at the Open Waters Guelph and Halifax Jazz Festivals and also performed in contexts that span Berlin's Volksbühne and Jazz Am Helmholtzplatz to Acadia University's Physics Department. She is the winner of the 2025 Paul Cram Award and will be debuting her first piece for symphony in January of 2026 with Symphony NS.
BUFFALO, NY — May 12, 2026 — A new #research paper was #published in Volume 18 of Aging-US on May 4, 2026, titled “Host immunosenescence compromises Mycobacterium tuberculosis clearance.” The study was led by first author Falak Pahwa and corresponding author Ranjan Kumar Nanda from the International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi, India. In this study, the authors investigated how aging alters immune responses during tuberculosis infection and treatment. Tuberculosis remains one of the world's deadliest infectious diseases, and older adults are particularly vulnerable due to immunosenescence, the gradual decline of immune function that occurs with aging. Despite the growing burden of tuberculosis in aging populations worldwide, most experimental models continue to rely on young adult animals that do not accurately reflect immune aging. Using multiple age groups of C57BL/6 mice, the researchers examined how aging affects the body's ability to control Mycobacterium tuberculosis during treatment with rifampicin and isoniazid (RIF-INH), two cornerstone anti-tuberculosis drugs. While young and older mice initially showed similar bacterial burden following infection, older mice demonstrated significantly delayed bacterial clearance in the lungs during the early phase of treatment. Importantly, the study identified several age-associated immune abnormalities linked to impaired bacterial clearance. Older mice exhibited chronic inflammatory signaling, altered T cell responses, accumulation of T-follicular cytotoxic (TFC)-like cells, and evidence of mitochondrial dysfunction within immune cells. Proteomic analysis of splenic CD4+CD44+ T cells further revealed dysregulation of mitochondrial proteins involved in cellular metabolism and immune function. “Collectively, these findings suggest that age-associated immune alterations may disrupt immunometabolic pathways, thereby contributing to the delayed Mtb clearance.” The researchers also observed that older mice maintained elevated inflammatory cytokine levels and developed persistent lung inflammation even after treatment had begun. At the same time, key protective immune responses appeared functionally impaired, suggesting that aging may disrupt the balance between inflammation and effective pathogen control. Together, these findings suggest that age-related immunometabolic dysfunction may play a major role in the reduced treatment response observed in older hosts. Notably, the study found that delayed bacterial clearance in older mice did not appear to result primarily from liver toxicity or impaired drug metabolism. Instead, the evidence suggested that age-related immune dysfunction itself was the dominant factor limiting effective bacterial elimination during therapy. The paper further highlights the emerging importance of mitochondrial health in immune cell function during aging. The authors propose that targeting age-associated immunometabolic defects and mitochondrial dysfunction may represent a promising strategy for improving tuberculosis treatment outcomes in elderly populations. Overall, this study provides new insight into why older adults experience poorer tuberculosis outcomes despite receiving standard therapy. As global populations continue to age, understanding how immunosenescence alters infectious disease responses may become increasingly important for the development of more effective treatment strategies and age-adapted therapeutic interventions. DOI - https://doi.org/10.18632/aging.206374 Corresponding author - Ranjan Kumar Nanda - ranjan@icgeb.res.in Abstract video - https://www.youtube.com/watch?v=isPD8ZmUjv8 Website - https://www.Aging-US.com MEDIA@IMPACTJOURNALS.COM
The little things are often the big things.The problem is we often focus on the big things while the small things quietly sink the ship.In this episode of Life at Ten Tenths, Garrett and Matt unpack the small friction points that quietly create stress, slow momentum, and damage the client experience.They're not the obvious issues, or the market shifts. They aren't even the big mistakes we obsess over and let ruin our sleep. They're the subtle ones:• The unclear communication • The inconsistent follow-up • The confusing onboarding process • The unexpected inspection surprise • The undocumented systems that only you understandIndividually, they seem minor. Collectively, they cost you referrals, energy, and growth.In this conversation, we explore:• How unnoticed friction points create burnout • Why client stress often starts with process gaps • The difference between “that's just how real estate works” and a broken system • How to identify friction before it becomes a problem • Why process clarity makes you more referable • How eliminating friction fuels your life instead of consuming itThe best businesses aren't just productive. They run smoothly.Smooth businesses create confident clients.If you want fewer headaches, stronger referrals, and a process that feels steady instead of chaotic — this episode is for you.
Last year, the GOP's legacy donor class and its newer crop of tech and finance billionaires found common cause: writing enormous checks to support Donald Trump. In February, billionaire Kelcy Warren and his fossil fuel pipeline company, Energy Transfer, each sent $12.5 million to MAGA Inc., a Trump-aligned super PAC. Just a few months later, OpenAI cofounder and president Greg Brockman and his wife cut checks for $12.5 million each. That makes Warren and Brockman the biggest individual donors to MAGA Inc. But the roster is deeper than two names and four eight-figure checks. Forbes counts at least 24 billionaires or billionaire families who have given over $1 million, according to Federal Election Commission filings covering through the end of March. (Brockman is not currently on Forbes' list of billionaires, but he did claim to be one in testimony related to Elon Musk's lawsuit against OpenAI). Collectively, these ten-figure club members, plus Brockman, donated $118 million, about a third of the $350 million war chest MAGA Inc has built. By Kyle Khan-Mullins, Forbes Staff Learn more about your ad choices. Visit megaphone.fm/adchoices
Welcome to the Celestial Insights Podcast, the show that brings the stars down to Earth! Each week, astrologer, coach, and intuitive Celeste Brooks of Astrology by Celeste will be your guide. Her website is astrologybyceleste.com.
What Lives in the BasementThis is a week of pressure, depth, and reckoning.If you're feeling friction — between what wants to move in you and what the world seems to be asking, between your own pace and a larger momentum — you're reading the moment accurately.What is happening in the world is not separate from what is happening in us. The intensity in collective systems, the unraveling of familiar agreements about how things work — this is the outer expression of a reckoning that is also deeply interior.We are not observers of this moment. We are inside it.Key Cycles This Week:Monday, May 4: Mars in Aries squares Jupiter in Cancer. Heat and urgency meet complexity. A pull to act runs into questions not yet ready to be answered. Stay curious about what's driving the urgency — there may be something worth slowing toward beneath it.Tuesday, May 5: Mercury in Taurus squares Pluto in Aquarius. The surface explanation is no longer sufficient. Something beneath it is asking to be named. What is actually true here, beneath what is being projected or defended?Wednesday, May 6: Pluto stations retrograde at 5 degrees of Aquarius (remaining retrograde until mid-October 2026). This is the center of the week. When Pluto turns inward, the Transformer asks each of us to look at what we have kept in the basement. Old grief. Old agreements we didn't consciously choose. Old survival strategies still running in the background. Old stories about power.Collectively, we are watching what happens when the contents of the cultural basement begin to surface. The shadow of Western systems — the violence, the extractive logic, the domination long hidden or rationalized — is now more visible than it has been in generations.Pluto does not create what it reveals. It illuminates what was already present, waiting to be reckoned with.Sunday, May 10: Sun in Taurus sextiles Jupiter in Cancer. A softer note arrives. Groundedness meeting warmth. Let that in. It matters as much as the reckoning.Larger FrameWe are being asked to develop a capacity that dominator culture has systematically discouraged: the ability to remain present to what is difficult without checking out, numbing, or bypassing into false hope.The cultural shadow is surfacing. The personal shadow is surfacing. And the two are not separate.The invitation is not to fix everything. It is to stay awake, stay connected, and let the reckoning be real without letting it be the only thing that is real.Reflection QuestionsWhere am I feeling friction between what wants to move in me and what the larger moment seems to be asking?What might be living in my own basement right now — something I've been working around or haven't yet had room to name?As the collective shadow surfaces, what helps me stay present without collapsing into despair or turning away?Stay close to what is real. Stay connected to others in the ways that cannot be automated. And remember, even in times of deep reckoning, life continues to reorganize within the larger web of life.Podcast poem: Fearing Paris by Marsha Truman Cooper. Support the showGo to Sheila's website for information for transformational resources: https://www.ontheedgesofchange.comThis episode was co-created with generative AI, engaged as a soul-aligned ally in service of transformation. At the edge where technology meets myth, I choose insight over noise, and alchemy over automation. Thank you for dreaming the future with me.
He's not going the wrong way, he's just going HIS way! In this episode of Talk About It, Greg sits down in studio with Loren Zitomersky - A.K.A. the "Backwards Guy." Loren has gained a ton of publicity over the years for attempting to break the world record for fastest marathon run backwards, and he does it all in the name of raising awareness for epilepsy! Before he was born, Loren's dad had a son who tragically died due to SUDEP, so he has devoted his athletic life to his brother's memory. Collectively, he has done over 80 interviews or televised segments with Inside Edition, the Boston Globe, Runner's World, the Associated Press, as well as various local and international news outlets, and has raised hundreds of thousands of dollars for epilepsy research! In addition to being Backwards Guy, he also runs a very popular social media channel called The Legal Beef. From his exdperience as a corporate lawyer, Loren is now harnessing his knowledge and expertise to provide the public with legal breakdowns and advice from viral social media clips. Naturally, his passion for epilepsy advocacy was eventually going to find its way into this venture, so we are so excited to be partnering with Loren on a series of short videos he produces for Talk About It on caregivers and epilepsy-related legal questions! Go to our website at TalkAboutIt.org to find those short clips. Know your rights, and also know that when you feel like you are going backwards sometimes, you're still moving forwards in the big picture. Talk About It with Greg Grunberg is excited to be sponsored by Neurelis and by Jazz Pharmaceuticals.
The evolving legal and operational landscape for autonomous vehicles (AVs), specifically within Texas and Arizona. Legislative efforts such as Texas Senate Bill 2807 and the federal SELF DRIVE Act aim to establish safety standards, data reporting mandates, and clear licensing protocols for driverless commercial fleets. Beyond regulation, the texts explore complex liability frameworks, debating whether manufacturers should be held to a strict liability standard or a "reasonable human driver" benchmark during accidents. Real-world implementations are also highlighted, including the expansion of Tesla and Waymo robotaxis and the resulting challenges for law enforcement regarding traffic citations. Additionally, a regional survey contextualizes the political climate in these states by comparing public attitudes on polarized issues like abortion access and governance. Collectively, the documents illustrate a transition toward a future where automated systems must be integrated into existing societal and judicial structures.
How can we connect to our authentic power, especially if we work in the field of spirituality, healing or the helping professions? And why do so many healers collapse or avoid their power as soon as they are ready to expand their service?In this episode, we talk about the womb as an energetic reality. Collectively, most of us have been disconnected from the womb energy and Divine Feminine traditions. As a result, we are also disconnected from authentic power that resides in the Divine Feminine realm of the womb. We feel it especially acutely when we move into a feminine territory of healing and selfless service. In this episode, I discuss:- how we can connect to authentic spiritual power;- how we can balance and transform old healer and do-gooder templates (and why they are connected to the Feminine);- what is womb energy (everyone, any gender, has a connection to it!);Plus a guided attunement and energy meditation. You can find out more about my work on: healing-radiance.com/harmonic-reconnection-healing
A shifting landscape in the artificial intelligence sector, dominated by massive financial commitments and escalating infrastructure needs in 2026. Amazon and Google have significantly deepened their partnerships with Anthropic, committing tens of billions of dollars to provide the essential compute capacity and custom silicon required to scale the Claude AI models globally. While official valuations for Anthropic remain around $350 billion, speculative activity in secondary markets has driven its implied worth toward a staggering $1 trillion. Meanwhile, Meta has reported record-breaking revenue and profits, yet its stock faces pressure as investors react to the company's decision to dramatically increase its capital expenditures for AI development. Collectively, the reports highlight an aggressive "arms race" where tech giants are prioritizing long-term dominance in generative AI over immediate profit margins. This era is defined by a circular economy where cloud providers act simultaneously as primary investors and infrastructure vendors for leading AI labs.
In this episode, we celebrate 10 years of the Participant Panel and explore how genomic research is being guided by patient and participant voices. Made up of people who have consented for their genome, or the genome of their loved one, to be included in the National Genomics Research Library, the Panel plays a vital role in shaping how research is designed, how data is used, and how genomics is communicated. From influencing policy discussions to to advising the Genomics England board, their work helps ensure lived experience is embedded from the very beginning. Over the past decade, the Panel has driven meaningful change. From advocating for greater transparency and accessibility, to challenging how the genomics community talks about genetic conditions. But beyond the impact, this episode focuses on the people behind the work: their motivations, experiences, and the realities of representing a wider community. Our host, Sharon Jones is joined by: Kirsty Irvine – Chair of the Participant Panel and member of the NHS Genomic Medical Service People and Communities Forum Lisa Beaton - member of the Participant Panel, panel member for the North East and Yorkshire GMSA and research and development for Harrogate Hospital Foundation Trust Frances Allan – member of the Participant Panel and member of the following: CRUK Women+s Cancers PPIE at Cambridge MHRA Yellowcard Biobank Northumberland NHS health forum Ovacome Healthforum IMPRESS cancer diagnostic tool study participant You can find out more about the Participant Panel in our recent Genomics 101 episode which Lisa featured in, titled ‘What is the Participant Panel?', and you can read about their timeline of achievements over the last 10 years. “One of the things as participants that we're always really keen to get across, particularly to the scientists, is that behind every piece of data is a face and a name” You can download the transcript, or read it below. Sharon Jones: This time on Behind the Genes, we'll be celebrating the 10th anniversary of the Participant Panel, and we'll discuss how genomic research is being guided by patient and participant voices. The panel is made up of participants whose data is held in the National Genomic Research Library. They help us to put lived experience at the heart of our work. My name is Sharon Jones, and in this podcast we cover everything from cutting-edge research to real-life stories in genomic healthcare. Joining me this time are Kirsty Irvine, chair of the Participant Panel, and Frances Allan and Lisa Beaton, who are also both members. Collectively, they wear many hats for a range of organisations, which are listed in the episode description. As you'll hear, this one is all about people power. So back in 2016, the Participant Panel was in its infancy, with 12 founding members bringing lived experience of rare conditions. The idea was straightforward but radical: that the people whose genomes were being sequenced should have a real say in how the work was done. Over the decade since, the Panel has shaped some significant changes, from pushing for a service that let participants track their own samples, to publishing a language guide that changed how the genomics community talks about genetic conditions and disability. They've navigated the pandemic, welcomed new members and, in 2025, launched their first formal strategy. This year they mark their 10th anniversary, and today we're hearing from some of the people who've been part of that story. So welcome Kirsty, Frances and Lisa. So what was your reason for joining the Participant Panel? And I will ask Frances that. Frances Allan: Hi Sharon. I joined the Panel back in 2023 following a cancer diagnosis, and as part of that investigation I was fortunate enough to have a whole genome sequence performed. And they also asked would I be interested in taking part in a panel who look after this information, and I ticked the box and then thought no more of it. And then a month or so later I heard from the then Chair, Jillian, um, and had a chat about genomics and joined the Panel, and it was a very good decision that I made. Sharon Jones: Did you have any kind of expectations? What were your early thoughts when you kind of accepted? Frances Allan: Not many thoughts. So I was in the middle of my chemotherapy treatment, but one of the things that really stood out: when I signed the consent form, I said, well, of course I would do that. And the clinician consenting me, said, actually, not everybody does. And I thought, well, why would they not want to do that? So I was really interested in finding out about that. I had no idea how influential the Panel was, and that was great to discover as I became part of it. But seeing the breadth of the research and the knowledge already gained, compared to my rudimentary A-level Biology from many, many years ago, gave me incredible hope, um, and really helped me through a very difficult, difficult time. Sharon Jones: Yeah, that's, that's amazing. It's amazing that you could kind of think in that way whilst you were actually going through the treatment itself. I mean, how did you split yourself in that way? Frances Allan: I think it gave me a sense of, of purpose. So at the time, I'd, I'd stopped working to have my treatment and I was a, a vet previously, so I was used to thinking about medical things and problem solving, and it, it filled a, a void in my life. I had no idea I'd be able to contribute to it. I thought, well, I'd learn something from it. But, you know, the, the Panel is managed very well. Kirsty's a fantastic Chair. Everybody gets an opportunity to speak, and the attendance can be in person. And I've done most of them in person. When I was poorly I attended an online meeting, but even that is managed so well that you get a chance to speak up. If you're not feeling well enough, then you can, you can add it to the chat or email. So it's very, very inclusive and a very supportive environment, as well. Sharon Jones: Yeah, it sounds like a, a very safe space to be in. And Lisa, what was your reason for joining the Participant Panel? Lisa Beaton: I think it was sort of one of those, bit of a light bulb moment for me thinking, yeah, I could do that. I'm not quite sure why I felt I was qualified to do that, but my reasoning is slightly different than Frances. So I joined the 100,000 Genomes Project back in 2015 in respect of one of my children who has an undiagnosed, thought to be neuromuscular, syndrome. Um, so myself, my husband and our daughter recruited for genetic sampling, and over the years I've sort of taken a keen interest in all things genetic and genomic related, followed on kind of various social media platform. And I think if memory serves, I saw an announcement or an advert stating, do you want to be part of the Participant Panel, clicked on the link and thought, this is something that really resonates with me. I've served with different hats on different kind of participant groups and speaking events, and it's something I feel really, it's an overused phrase, but I do feel really passionate and strong about it because, you know, we are the people who are the front and centre of this, because it's our genetic information. So I applied, did a bit of a kind of resume of myself, um, then had huge imposter syndrome and thought, oh, that'll be the last I'll ever hear of that. And uh, actually had a really lovely interview with some of the then, uh, members of the Panel and must have said a few of the right things, 'cause here I am, three years down the line. Sharon Jones: That's amazing. Has it lived up to your expectation? How has it, how has it helped you get through what sounds like a really challenging time? Lisa Beaton: It's, it probably sounds wrong to say I, I didn't really have an expectation, but I joined it really just wanting to kind of know more and see if I could find out more details, more information, kind of more genomic discovery, and hope that I could give something back, if that doesn't sound too cringey. I think one of the things I'm always really keen to say is that you don't need to be a geneticist. You don't need to be a scientist. You don't need to kind of have lots of scientific information. And I will confess that the very first meeting I went to, I did come away thinking, I think I probably only understood about one word in three. But three years down line as I say, I'm still here, and it's been good to challenge myself and to explore kind of things that I don't know information about, but also I found that there are areas that I can definitely bring lived experience to and, and hopefully a voice for people like myself and my family. Sharon Jones: Yeah. That's so important. It sounds like you've become a bit of an expert by, uh, experience there. Has your vocabulary improved in the last three years? Do you know more words now? Lisa Beaton: Yes. Uh, I've, I have to remind myself not to use an acronym. It's one of my pet peeves. You know, when you're, you're in a, a meeting and terminology or, or vernacular, that is not necessarily something that people would use day-to-day, and I think lots of you know, you don't, don't have to be genomics or genetics to, um, using acronyms for things. It's something we all need to remind ourselves that just because you know that expression, somebody else doesn't. So it's really important to kind of keep that at a, a lay explanation so that everybody understands it. Um, I think particularly with quite heavy subject matter such as genomics and genetics, there can be a tendency otherwise for people to feel that it's not for them. And of course it is, because it's about our own personal data. Sharon Jones: Yeah, absolutely. And, um, and coming to you, Kirsty, what were your kind of motivations for, for joining the Participant Panel? Kirsty Irvine: Well, it's been quite a long journey for me to find myself on the Participant Panel, so I and my family, we were all consented into the a 100,000 Genomes Project back in 2015. But from that point, I then spent nearly 10 years chairing committees at NHS Digital and then NHS England, focusing on health data access. And I remember talking about the 100,000 Genomes Project at my interviews for those roles. I then went down a different path. And in those roles I was very much wearing my solicitor's hat. So I was thinking about governance and risk and were we complying with the precise wording of the legislation. And then when the chair role came available, I had a number of people sort of forward it to me saying, I think this would suit you. I think this would suit you. And at that stage, I was aware of the Panel because I'd met the fantastic former chair, Jillian. Um, so I'd seen Jillian at various conferences and meetings and things, so I was well aware of what the Panel did. I was well aware of the Panel's standing. It was probably the only participant panel that I was aware of in my work with NHS Digital, NHS England. And then I realised, you know, I wanted to be closer to the people behind the data and I wanted to do something more active. I wanted to bring a bit more of myself. Because when you're chairing a very formal committee, at NHS England, you, you can't talk about the time that you resuscitated your child at home, you know? And on the Panel, you know, my very first meeting, I, I met someone, someone whose child had, you know, been fed with an NG tube for a number of months. You know, I met someone else who had resuscitated their child, you know, and all of a sudden I could bring more of myself to my colleagues and, and find a real community. So for me, joining the participant panel was a way of shifting the perspective, but to also bring that experience with me because I, the roles at NHS England, you know, from a governance perspective, I couldn't continue chairing those, you know, board subcommittees forever. But I didn't want that knowledge to just sort of disappear. So for me, I'm really delighted that I've, what I hope, what I hope is a good fit. I feel it's a good fit. So that, that's been my journey to the Panel. Sharon Jones: Yeah, that's, that's so interesting. And I guess having that space to kind of be yourself, and having understanding because of your lived experience, brings a lot of value to the role that you're doing now in a way that kind of is different when you're in your previous roles of NHS Digital, because you had to be a bit more, kind of stand back from it and, yeah. That's so interesting. So, what has it been like being part of these groups? You know, the ones that you kind of, you're involved in a lot of things, and we'll list them in the, in the web description. And how has it kind of affected your life, essentially, because it's not the kind of average thing that people are involved in. Frances Allan: So it's been an incredible, I think as Lisa alluded to, incredible learning curve. We've learnt so much. But the team at Genomics England are endlessly patient and very skilful at passing that information on. And we have access to the leading researchers, the clinicians that are involved in genomics. And they're happy to take any question. And the questions, however silly, there's no silly question. They're happy to answer that. And so we learn every time we attend a meeting, we have quarterly meetings and that can be in person or online. Um, but we also have regular lunch-and-learns. So if there's somebody we want to speak to or find more about their specialist area, they'll come and have a, a chat with us. And then we have half of it, them chatting to us and half us, us. Us asking them questions and, and challenging them. Um, so it's very, very informative and then learning from each other. And as Kirsty was saying, you know, this is a, a group of people who've, who've dealt with an awful lot of unique situations and they're happy to, to share that and pass on the information. It's a, it's a great place of learning. Sharon Jones: Lisa, would you agree with that? How it been for you? Lisa Beaton: Yeah, I would definitely echo everything that Frances has actually said there, and I think it's a very humbling experience, as well. Ostensibly, we are a, a collection of individuals who have all been brought together, um, purely because of, uh, our genomic interests. And whether that's for our families, you know, as, as parents, as in my case, or in somebody like Frances' case, who's obviously a participant in her, in her own right. And although there are kind of many differences in our stories, there's also a lot of similarities. But I think what's really interesting, very precious, is that the staff at Genomics England, obviously they range from, you know, there, there's so many different kind of areas from the, the comms, the scientists, etc., but everybody is really interested. They want to know your story, who you are, why you are there. There's a real kind of inclusion focus on that. And one of the things as participants that we're always really keen to get across, particularly to the scientists, is that, you know, behind every piece of data is a face and a name. And I think they really make that felt when they're chatting to us. You know, we go in and, and there, there's people who are there from governance sides for how the data is accessed by other parties. There's people there who are the science technicians, etc. There's people who are dealing with the administrative side of things, but every single person that I've encountered wants to know more about you, what you are there for. And that is, is very, very precious. And as Kirsty also alluded to, a lot of us have been through some really quite traumatic experiences. It, it's not my place to speak of others' journeys, but you know, there, there are, uh, bereaved parents and family members among us. And so we are sharing very precious raw material, emotions, experiences, and that is very powerful, as well. And I, I think the Genomics England staff never forget that. They seem to bear that at the forefront of their, their communications with us, always. Um, and certainly Kirsty and Adam and previous chairs, uh, of the panel, that inclusivity was entirely throughout every dealing we had with them. Sharon Jones: It's very humanising and I think that it's humbling for us who work here that that's always at the forefront of our mind, that this is why we kind of get up and go to work every day, because of that human element. And it's not just a data point. There is a whole family, a story, a history, and that's, that's so important to us in the work that we do. Kirsty, did you want to add your point on this as well? Kirsty Irvine: I've probably got two points I wanted to raise. One was just to draw out what Lisa was saying, is that it can be complex being a Panel member, because the story you're bringing often isn't just your own. In my family, we've got a real, we've got a whole range of genetic differences and conditions that, you know, across the extended family. And so when I speak, I'm often drawing on experiences that aren't solely mine to share, and, you know. So I think that's something that for some on the Panel, we're sort of, we're, we're being quite careful to think about what we're saying, and if we're speaking in the public domain, we might be talking about it in more general terms. So that's, you know, but there's not a single right way, and there's room on the Panel, everyone, for the people who can and, and as Lisa talked about, you know, the, the most acute situation is where someone's bereaved, you know. And it's, so everyone's got different, you know, different experiences. But that, that, again, coming back to the positive side of things, one of the biggest things to me about being on the Panel, what it means to me, is being part of a wider community. I mean, one of the other things that, Sharon, I don't know if I can sort of segue onto this about, you know, the opportunities that have arisen? Sharon Jones: Yeah, absolutely. I'd love to hear more about that. Kirsty Irvine: So one thing that really stands out for me was the opportunity to speak directly with, um, Associate Health Minister Ahmed about, and his policy team. So we went to the department, Adam and I went to the Department of Health, and it was about the use of GP data in consented research cohorts. So getting the GP data into the National Genomic Research Library. So even though there's consent, up until now, that GP data, that tranche of really rich data, hasn't, hasn't gone into the NGRL. So I'll use that abbreviation now that I've used it in full. And so what was really unique for me was that I'd seen it from multiple angles because I'm participant in the 100,000 Genomes Project, so I'm a cohort member. I then worked on the consent review for NHS England. I then sat on a, the consent review assessment committee with, you know, a multiparty group. And then, because I was on the panel, I got to see things full circle. I was then invited to, to go and meet with, um, Minister Ahmed and, and advocate for the use of this GP data. And that really matters because something, you know, there's such important information sitting in that GP data and it wasn't a given, it was not a given that the government was going to the direction that allowed that data to go into the NGRL. And so we were able to talk about how we really wanted that data to be used. And now, going forward, you know, something as simple as BMI or for example, if a, if an individual's coded for a neuro, neurodevelopmental condition like autism, sometimes that data actually only sits in the GP health record. It's in primary care only, so it's not necessarily in the hospital records or other records. And so this is really, really valuable data for, for researchers. And so that was something that was a really special experience, just being able to see that come full circle. And I felt like it's a really tangible example of how the participant voices really helped strengthen that conversation, you know, with the DH policy team, you know, and the government ministers. Sharon Jones: Yeah, I mean that's, that's really powerful and it, it just sort of shows how these opportunities can arise from being involved in a participant panel in a way that you wouldn't have necessarily had that power if you hadn't been involved. And you know, obviously you are wearing lots of different hats in that, in that position, Kirsty. And um, it just sort of shows what can be done when you're, unfortunately, you know, you're in this group for a reason and it's not necessarily the, the most cheeriest reasons, but it, you still leverage that opportunity to create something positive, you know, with it. Frances Allan: So we've given all sorts of opportunities and we seek to get involved with as many things as we can to speak and have our voice heard. Um, and one of the things I did last year was, um, do a short presentation to open a stage at the Genomics England Research Summit, which was quite a challenge for me, but I felt very exhilarated having done it. And then a couple of people came up afterwards and just said, oh, thank you for sharing your story. And a researcher who was slightly older than I, so very experienced, been in his field a long, long time, and he said his clinical years were long behind him, and now he researches within a lab. And actually for someone to say, you know, thank you for, for looking, thank you for finding, had a very profound experience on him. And he knew there was a clinical benefit; his research was very clinically led. But he said he hadn't thought about the recipients of those findings. And I pointed out every time you have that chat with somebody, come to an event like that, have a network, spend a bit longer in the lab, look for something that you might not find, even if it's a negative finding, there will be somebody eventually that benefits from that. And I've been a direct recipient of other people putting forward their whole genome sequence, and then a common change was noted in people with the type of cancer that I have, and that then qualified me for a treatment that otherwise I wouldn't have been eligible for, and I wouldn't have been, I wouldn't have been here now. So it's a very, you know, profound thanks to all the people that are involved from everybody within Genomics England, all the researchers, all the other patients that speak up. We each have a contribution to make. Sharon Jones: Yeah, that's amazing. That must have been quite a poignant experience when you, you met him at the, um, Summit, of just kind of the other side of the, the world that you don't often see. And they obviously don't see our side of the world, and it's kind of interesting to join those dots and kind of come full circle. So moving on. In terms of like, collectively, there's a lot of impact that you have and there's a noticeable shift in organisations where people with lived experience are playing, you know, a much bigger role in decision making. Can you help our listeners understand how people are getting involved in governance and shaping research? Lisa Beaton: From my perspective, it comes back to that word "embedding". I think historically, perhaps there's been an, an almost about-face. Um, it's kind of come at it very backwards, that that embedding has almost happened as an afterthought, which is sort of a bit of a misnomer way of explaining it. When you're talking about embedding, obviously it should be the foundation. Historically, at least both from the parent, parental perspective, I've seen that with clinicians, for example, that historically I've been made perhaps to feel a bit of a thorn in someone's side, that even though we're there for an appointment about our young person, when I'm asking questions that they don't necessarily want to answer, you know, I'm almost the, the add-on rather than the reason that we're there. And I think there has been a paradigm shift in everybody's approach to that. So thinking much more about, you know, the, the what's, the wherefores, the whys. How do we ensure that right from the get go, that patient or participant voice is heard, and it shapes the question. And one of our other Panel members frequently uses the phrase, "nothing about us without us", because that is front and centre of why, you know, genomics exists in the first place, really. Without that data, the conversation ceased to exist. It, it's so vitally important, not just for us as an individual, not just for our family members, but for the greater good, if that doesn't sound too grandiose. Sharon Jones: No, not at all. And, and, and Frances? Frances Allan: I think having raised that value of patient advocacy: what we have to say. So it started off, people felt that they should have some, so they included it, but actually once they started to include it, they thought, this does contribute to our study. And starting at the very beginning of the research project, so what is reasonable to ask participants and patients to do? Is it something that there is benefit from? And trying to see that end goal right at the beginning. And we might help shape a research study that actually goes in a beneficial direction, rather than the researchers starting alone, and then actually getting into the study, and the procedure is, is too painful to endure, there's no clinical benefit, it's not something that can be translated into clinical practice, and it gets abandoned. So start us right at the very beginning, and our perspectives may not be what, what researchers or clinicians think. Uh, with that lived experience, however empathetic you are, the lived experience is a very unique lens and position to look from. Sharon Jones: Yeah, it absolutely is. So, given that you are part of a small group and you know, you're representing a much wider community, essentially, like, what are the considerations that you, you have to bear in mind? Lisa Beaton: I think we can only speak, obviously, to our own individual experience and we are very aware that, you know, diversity, ethnicity, inclusion is something that is a much bigger conversation and certainly something that we want to broaden in, in the panel itself. And I know there's kind of lots of work and thought going into how that can widen those perhaps more diverse communities that historically... It's not that, there's, there's been a terminology that, you know, they're difficult to access, but actually the question is wrong there. The statement is wrong. It's not that they're difficult to access, it's just that we've been asking that incorrectly. And we need to ensure that they are, uh, empowered to bring their stories forward and find ways to push forward for their inclusion. We need to ensure that everybody's voices are heard, otherwise the data set is wrong from the off. So I think that's something that we're all very minded when we speak about, and definitely want to, to diversify the pools of data that come in. That, that has huge resonance for, you know, shaping genomic and genetic policies moving forward, for sure. Sharon Jones: Yeah, definitely. Frances, sort of broadening out that question. Does it feel like a lot of pressure and a lot of responsibility, kind of representing, you know, in this kind of small group where you are almost speaking on behalf of, you know, a lot of people? Frances Allan: I think it mainly feels like a, a privilege, Sharon, to be in that position, to have a say. And back to my, one of my motivators for joining is why would people not choose to do this? And actually understanding why that is. And is it the, you know, the lack of knowledge of genomics? And there is a lot of, of fear about what can be discovered. But understanding the immense benefits from that so people don't miss out on those opportunities. Our genomes contain the, the blueprint to us, but also how we would respond in certain situations, and you want everybody to be using those leverage points. You know, cancer's a really difficult disease to manage, and anything you can do to make it slightly easier, slightly more comfortable, slightly more successful, we want to do that. So every time we speak out and we advocate for the benefits of genomics, we might gain one more person who's going to feel that a successful outcome. Sharon Jones: Yeah, and who knows what, what that can mean for their family and, and sort of further down the line. So have you got any advice for, or encouragement, or any tips for, you know, potential participants who are thinking of getting involved in, in groups? You know, it doesn't necessarily mean the Participant Panel, but just generally, sort of groups related to their conditions or their family's conditions. Frances Allan: Yeah, I think the value of the one's personal experience: don't underestimate that. Everybody has an individual journey and they can comment and reflect on that. And anybody interested in, in joining our panel, you can include in the, the copy or description, ways they're getting in touch with us and speak to us about what that, what that involves. And uh, Lisa said at the, the beginning, you come and it's a huge learning curve, but there are people to support you and guide you through that way. And the learning is, is just fascinating. And there's a position for everybody and everybody's point of view to be heard, and you will be heard. Sharon Jones: Thank you. Lisa? Lisa Beaton: Yeah, I think I might steal a phrase or two actually from some, uh, well-known brands. But, um, one would be "just do it" and the other would be "feel the fear and do it anyway" because, you know, you are amongst friends, first and foremost. We all, we do tailor our experiences, and clearly we self-censor at times because that's necessary to protect the privacy and dignity of not necessarily ourselves, but as we've already alluded to in our chats, but you know, our family members, the wider people that you are aware will be hearing this. And you don't necessarily want certain medical information about your family members out there, because it's not your information to share. But in terms of joining the panel and, you know, having a voice, giving more voices, giving more diverse data, we, we need as many people as possible to come. We need more voices. We need to get our genetic, genomic information out there, uh, in front of the researchers and, and all involved with Genomics England, um, and other patient advocacy groups, as well, because that will only benefit the greater public. Sharon Jones: Thank you. And Kirsty? Kirsty Irvine: I'm just thinking about sort of general tips building on what Lisa and Frances have said. You don't need to be a seasoned public speaker. I think that's something, absolutely not. We've got some fantastic speakers in the group. Um, but then we've got people in the group who've got, who have got different skills, so don't think that you need to be ready to give a TED Talk at the first meeting, be that the Participant Panel or whatever group you might be motivated to join. We, we just need good listeners. I've chaired meetings in the past where people, uh, wanted to contribute via the chat function, and that worked absolutely fine. They would put their incredibly insightful, erudite comments in the chat, and then I would relay them to the group, and that was how we got that person's input, because we realised that they weren't necessarily going to speak up in the forum. So whatever your communication style, we can accommodate it at the Participant Panel and we would be delighted to hear from you. Sharon Jones: That's great. Thank you. Um, final question. So what do you hope the next 10 years of participant involvement will look like? Kirsty Irvine: I think if I could use a little catchphrase, which I'm sure is not mine, but I would like to see us fully integrated as partners, not participants. I'll put that out there. I mean, Sharon, I wonder if I could sort of also open things up to how are things going to look in another 10 years, because there's been some statistics that have really struck me, uh, at presentations that, that we've heard. One of them being that in the next, you know, within 10 years, around about half the data in the National Genomics Research Library will be from, I don't know if this is the best name for it, the general population. So that's people who aren't necessarily seeking an answer, or have a diagnosis or a condition. These are people who have donated their genomic data through being part of, you know, research projects. And, as a panel, so Genomics England's evolving and the panel will be evolving. And in 10 years time, the panel will need to be, I believe, true to the original route. So, 100,000 Genomes Project. Uh, the people who've had their whole genome sequencing through cancer diagnoses. You know, there's a significant COVID cohort, but also people of the gen, general population. So how do we advocate for and look after everyone in that broad group of people. So I think that, that's both a challenge, that's a challenge for us, but it's also really exciting to think how we can meet that challenge. Sharon Jones: Yeah, definitely one, definitely an opportunity and a challenge, and one that will take a lot of thinking in the next few years. Frances? Frances Allan: Yeah, thanks Sharon. I think looking forward to that, that 10-year period is how genomics just becomes a normal part of everybody's healthcare, so we all fully understand the benefits of it. People are willing to participate in it and then using lots of different types of data to go into the National Genomics Research Library. So at the moment, it's mainly genomics material, but there's been a lot of work done with the cancer cohort, putting in diagnostic images, pathology slides, other clinical data, written notes, and this can then be accessed under the strict criteria of the access review committee. It can be accessed by clinicians, researchers across the world. And we want our research library to be the premium source of that information and to have collaboration with researchers, clinicians, participants, worldwide, to speed up the generation of that information and those positive outcomes. It's a, a very, very rich data source now, and it'll only get bigger as we include people from the general population. Sharon Jones: That'd be amazing and have some quite incredible global, um, outcomes. Lisa? Lisa Beaton: I just had a little image actually pop into my head that I, I almost look at it a little bit like we're doing one of those, I think they might be called an "impossipuzzle" where actually we don't have the picture on the box, but we have lots and lots of little pieces that are all going in together and they're making up a really creative, wonderful, fantastic, woven story, a tapestry as you were, of different information that's coming through. And how incredible, you know what, what a wonderful legacy we're building, you know, and this amazing picture that's going to evolve and change and develop over the years to come. Sharon Jones: That's a wonderful note to end on, so we're going to wrap it up there. Thank you for listening. A special thanks to our guests, Kirsty, Frances, and Lisa, for joining me today as we discussed how lived experience can shape health research. If you'd like to hear more like this, please subscribe to the Behind the Genes on your favourite podcast app. And if you want to know more about the Participant Panel, you can head to the Genomics England website and listen to our 10-minute explainer podcast, Genomics 101. Behind the Genes is produced by Deanna Barac, Florence Cornish, Sophie McLachlan and Dave Howard at Bespoken Media.
The evolving infrastructure and policies surrounding Tesla's Supercharger network and the broader future of fueling stations. Tesla is implementing congestion and idle fees to ensure chargers remain available, while also piloting a virtual queue to manage high-traffic periods and prevent driver conflicts. Concurrently, the company is utilizing incentives like free charging to drive sales for specific models. On a wider scale, traditional gas stations are transitioning into multi-energy hubs by integrating EV charging and alternative fuels to remain viable through 2030. Collectively, the texts highlight a strategic shift toward automated management and diversified energy offerings to improve the electric vehicle ownership experience.
Welcome to the Celestial Insights Podcast, the show that brings the stars down to Earth! Each week, astrologer, coach, and intuitive Celeste Brooks of Astrology by Celeste will be your guide. Her website is astrologybyceleste.com.
In this episode of NOON we have Mike Worthen.Mike has been in emergency services since 1989, he worked in private ambulance, fire department, as a flight medic, and even time at the County Coroner's Office. More than three decades in this profession have shaped how he sees both the job and its emotional cost.We talk about the weight first responders carry, how detachment can protect us but still follow us home, and why culturally competent mental health support is critical in our field.Podcast: https://open.spotify.com/show/1vAokfqG5aifoRBKk9MAUh?si=T8DipSBCQzWfOeiBW3h-VwFB Page: https://m.facebook.com/groups/nineoneonenonsense/?ref=shareInstagram: https://www.instagram.com/911nonsense/X: https://twitter.com/911NonsenseBonfire Merch: https://www.bonfire.com/store/nine-one-one-nonsense/?utm_source=copy_link&utm_medium=store_page_share&utm_campaign=nine-one-one-nonsense&utm_content=defaultContent Warning: This episode contains discussions about death, including graphic and potentially triggering details. Listener discretion is advised. The episode also covers sensitive topics and may not be suitable for all audiences. If you or someone you know is struggling with suicidal thoughts or mental health issues, please seek help immediately. You can contact the Suicide & Crisis Lifeline by dialing 988 from anywhere in the U.S. #911nonsense #ParamedicLife #FirstResponderStories #EMSFamily #EmergencyCalls #SavingLives #BehindTheSiren #FirstResponderLife #911nonsense #ParamedicPodcast #PodcastLaunch #PodcastLife #PodcastCommunity #TrueStoryPodcast #NewPodcastAlert #PodcastAddict #PodcastEpisode #PodcastPromotion #PodcastHost #PodcastRecommendations #RealLifeHeroes #EmergencyServices #TrueStories #BehindTheScenes #LifeOnTheLine #AdrenalineRush #HumanStories #OnTheJob #EverydayHeroes #TrueLife
The rapid evolution of artificial intelligence, focusing on the technical advancements, regulatory frameworks, and economic shifts defining the current landscape. High-level research highlights how AI performance is surpassing human benchmarks in specialized fields while facing persistent hurdles in complex physical tasks and logical reasoning. A significant portion of the text emphasizes healthcare integration, detailing the intricate legal, ethical, and clinical challenges associated with decision-support tools and FDA oversight. To address issues like algorithmic bias and misinformation, developers are increasingly utilizing Chain of Thought reasoning and expert-led training methodologies to enhance model transparency and reliability. Additionally, the emergence of AI-driven recruitment platforms like Mercor illustrates how the technology is restructuring the labor market by connecting domain experts with specialized contract work. Collectively, the documents advocate for a transition from broad data scaling toward quality-focused, human-centric development to ensure safe and productive AI deployment.
Welcome to the Celestial Insights Podcast, the show that brings the stars down to Earth! Each week, astrologer, coach, and intuitive Celeste Brooks of Astrology by Celeste will be your guide. Her website is astrologybyceleste.com.
The salient point of this discourse elucidates the multifaceted challenges currently besetting the furniture industry, characterized by a confluence of financial pressures, uneven consumer demand, and significant restructuring at the supplier level. As we delve into the intricacies of the market, we observe alarming indicators, such as the Chapter 11 filings by prominent entities like Supernova Furniture and QVC Group, each reflecting broader shifts in retail dynamics exacerbated by evolving consumer behaviors and inflationary pressures. Furthermore, while consumer spending remains resilient overall, the furniture sector specifically underscores a more selective purchasing pattern, as evidenced by a decline in sales amidst a backdrop of rising costs and housing market constraints. This podcast episode meticulously dissects these evolving trends, elucidating the implications for retailers and suppliers alike, and posits that the industry is navigating a period of transition rather than outright disruption. In light of these developments, our focus remains on fostering adaptability, discipline, and vigilance in anticipating future trajectories within this complex landscape. The discourse presented in this episode elucidates the prevailing dynamics within the furniture industry, with an emphasis on the multifaceted pressures that are currently shaping its trajectory. Notably, we observe a juxtaposition of retail stress and supplier restructuring, which together create a complex landscape for industry stakeholders. A salient example is the recent Chapter 11 filing of Supernova Furniture, a regional entity operating in Texas, which has unveiled the fragility of certain retail sectors. This filing not only highlights the precarious financial position of the company—reporting liabilities that significantly overshadow its assets—but also serves as a bellwether for potential ripples throughout the supplier network, as the creditors involved encompass a notable array of industry suppliers. Such developments compel us to consider the broader implications of these financial maneuvers, particularly in relation to the evolving consumer landscape, where spending is increasingly selective amid rising costs and inflationary pressures. In addition to retail distress, the episode delves into the broader economic context impacting the furniture sector. While consumer spending has shown resilience, the specifics of furniture sales reflect a more nuanced reality; the data reveals a slight decline in month-over-month sales despite a positive year-over-year trend. This dichotomy suggests that while consumers remain active in the marketplace, their purchasing decisions are increasingly influenced by a focus on essentials rather than discretionary items. The discussion also touches upon the demographic shifts in home buying patterns, with first-time buyers dwindling to historical lows, thereby constraining the market for full home furnishing purchases. As the episode progresses, it becomes evident that the convergence of these factors—retail restructuring, selective consumer spending, and demographic changes—underscores a significant transition within the industry, necessitating a reevaluation of inventory and sales strategies among retailers. Finally, the episode addresses the global economic landscape and its ramifications for the furniture industry. The International Monetary Fund's recent adjustments to global growth forecasts serve as a harbinger of potential disruptions, particularly with respect to critical supply chains affected by geopolitical tensions. The discussion of the Strait of Hormuz exemplifies how external pressures can escalate costs for essential materials such as plastics and aluminum, thereby exerting additional strain on manufacturing processes. This multifaceted analysis not only highlights the immediate challenges faced by the industry but also suggests an enduring need for adaptability among companies as they navigate an increasingly volatile economic environment. Collectively, these insights underscore the importance of maintaining a disciplined and flexible approach to strategy as the industry grapples with an array of interconnected issues that could shape its future trajectory.Takeaways:In the current landscape of the furniture industry, financial pressures are manifesting in various forms, prompting both retailers and suppliers to reassess their operational strategies.The recent Chapter 11 filings by notable companies like Supernova Furniture and QVC Group indicate significant restructuring efforts, reflecting broader challenges within the retail sector.Consumer behavior is shifting towards a more selective spending pattern, wherein individuals prioritize essential purchases over discretionary items, thereby affecting furniture demand.The decline in first-time home buyers, now at the lowest percentage in over 40 years, poses a considerable challenge to the furniture market, as these buyers typically drive substantial home furnishing sales.Suppliers are increasingly focusing on internal restructuring and cost management to adapt to an unpredictable market environment, highlighting the necessity for agility in operations.Global economic factors, including geopolitical tensions and rising material costs, are exerting additional pressures on supply chains, compelling companies to rethink their procurement strategies.
Threats of a closed season in the Mississippi Flyway in 1968 led to intense disagreement, restrictive regulations, and amplified the challenges of managing the resource while considering the interests of people. Collectively, these times generated solid foundations for future progress. Dr. Mike Brasher is rejoined by Ken Babcock and Dale Humburg to discuss these topics, while also introducing an elegant alternative regulation system that began in the 1960s– the Point System. SPONSORS:Purina Pro Plan: The official performance dog food of Ducks UnlimitedWhether you're a seasoned hunter or just getting started, this episode is packed with valuable insights into the world of waterfowl hunting and conservation.Bird Dog Whiskey and Cocktails:Whether you're winding down with your best friend, or celebrating with your favorite crew, Bird Dog brings award-winning flavor to every moment. Enjoy responsibly.
Welcome to the Celestial Insights Podcast, the show that brings the stars down to Earth! Each week, astrologer, coach, and intuitive Celeste Brooks of Astrology by Celeste will be your guide. Her website is astrologybyceleste.com.
The world of science has been stuck in an existential crisis over whether we actually know the things we thought we knew. Re-running an old study today doesn't always yield the same result. Same with re-enacting old experiments. Collectively, this is known as the “replication crisis.” Economist Abel Brodeur has come up with one way to help fix this crisis: he's invented an internationally crowdsourced surveillance system, designed to keep social scientists honest. He calls it the “Replication Games.” Further Listening:Fabricated data in research about honesty. You can't make this stuff up. Or, can you? The Experiment Experiment How Much Should We Trust Economics?This episode was hosted by Mary Childs and Alexi Horowitz-Ghazi. It was produced by James Sneed and Emma Peaslee, with help from Willa Rubin. It was edited by Jess Jiang, fact-checked by Sam Yellowhorse Kesler, and engineered by Ko Takasugi-Czernowin. Alex Goldmark is Planet Money's executive producer. Find more Planet Money: Facebook / Instagram / TikTok / Our weekly Newsletter.Listen free at these links: Apple Podcasts, Spotify, the NPR app or anywhere you get podcasts.Help support Planet Money and hear our bonus episodes by subscribing to Planet Money+ in Apple Podcasts or at plus.npr.org/planetmoney.To manage podcast ad preferences, review the links below:See pcm.adswizz.com for information about our collection and use of personal data for sponsorship and to manage your podcast sponsorship preferences.Learn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy
© 2020-2026 Ivy Podcast Discovery LLC
